var title_f2_42_2720="Echo assessment rt ventricle2";
var content_f2_42_2720=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57522&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57522&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Echocardiographic estimate of right ventricular pressure in an infant with congenital diaphragmatic hernia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 213px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Estimates of right ventricular pressure are obtained by measuring the tricuspid regurgitation (TR) jet and adding this to right atrial pressure. The presence of a TR jet suggests increased pulmonary vascular resistance.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Holly L Hedrick, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2720=[""].join("\n");
var outline_f2_42_2720=null;
var title_f2_42_2721="Contents: Glomerular disease";
var content_f2_42_2721=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?0/41/670\">",
"       Nephrology and Hypertension",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Glomerular disease",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Glomerular disease",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Amyloidosis and fibrillary glomerulonephritis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/15/7418\">",
"           Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/31/31221\">",
"           Fibronectin glomerulopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/18/33064\">",
"           Glomerular diseases due to nonamyloid fibrillar deposits",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/62/35815\">",
"           Pathogenesis of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/9/35994\">",
"           Prognosis and treatment of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/29/13784\">",
"           Renal amyloidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/53/23383\">",
"           Treatment of secondary (AA) amyloidosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Diabetic nephropathy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/44/13000\">",
"           Aldose reductase inhibitors in the prevention of diabetic complications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/34/11817\">",
"           Glycemic control and vascular complications in type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/16/20745\">",
"           High albuminuria (microalbuminuria) and cardiovascular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/61/22484\">",
"           Mechanisms of glomerular hyperfiltration in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/49/42777\">",
"           Microalbuminuria in type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/33/39449\">",
"           Microalbuminuria in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/63/30714\">",
"           Overview of diabetic nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/18/39207\">",
"           Protein kinase C and the vascular complications of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/48/40714\">",
"           Treatment of diabetic nephropathy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Focal segmental glomerulosclerosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/31/43512\">",
"           Collapsing focal segmental glomerulosclerosis not associated with HIV infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/6/41066\">",
"           Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/59/33722\">",
"           Focal segmental glomerulosclerosis in the transplanted kidney",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/57/34714\">",
"           Treatment of primary focal segmental glomerulosclerosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hematuria",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/59/34746\">",
"           Etiology and evaluation of hematuria in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/20/27973\">",
"           Exercise-induced hematuria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/2/17445\">",
"           Glomerular hematuria: IgA; Alport; thin basement membrane nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/51/12088\">",
"           Thin basement membrane nephropathy (benign familial hematuria)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hereditary nephritis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/5/24663\">",
"           Genetics, pathogenesis, and pathology of hereditary nephritis (Alport syndrome)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/2/17445\">",
"           Glomerular hematuria: IgA; Alport; thin basement membrane nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/51/12088\">",
"           Thin basement membrane nephropathy (benign familial hematuria)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         IgA nephropathy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/19/1337\">",
"           Clinical presentation and diagnosis of IgA nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/2/17445\">",
"           Glomerular hematuria: IgA; Alport; thin basement membrane nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/28/39367\">",
"           IgA nephropathy: Recurrence after transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/48/20233\">",
"           Pathogenesis of IgA nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/54/5993\">",
"           Renal manifestations of Henoch-Sch������nlein purpura",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/7/42106\">",
"           Treatment and prognosis of IgA nephropathy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infection and glomerular disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/30/35304\">",
"           Poststreptococcal glomerulonephritis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/28/44488\">",
"           Renal disease associated with hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/30/37353\">",
"           Renal disease associated with hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/27/5556\">",
"           Renal disease in the setting of infective endocarditis or an infected ventriculoatrial shunt",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/28/34243\">",
"           Schistosomiasis and glomerular disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Lupus nephritis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/12/44233\">",
"           Clinical features and therapy of membranous lupus nephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/55/4985\">",
"           Clinical trials of immunosuppressive therapy in proliferative lupus nephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/3/27706\">",
"           Diagnosis and classification of renal disease in systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/32/28168\">",
"           Drug-induced lupus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/27/39352\">",
"           End-stage renal disease due to lupus nephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/42/41638\">",
"           Indications for renal biopsy in patients with lupus nephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/37/37466\">",
"           Therapy of diffuse or focal proliferative lupus nephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/3/12345\">",
"           Therapy of resistant or relapsing diffuse or focal proliferative lupus nephritis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Membranoproliferative glomerulonephritis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/51/43833\">",
"           Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/26/3498\">",
"           Dense deposit disease (membranoproliferative glomerulonephritis type II)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/17/13594\">",
"           Evaluation and treatment of membranoproliferative glomerulonephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/54/32614\">",
"           Membranoproliferative glomerulonephritis: Recurrence after transplantation",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Membranous nephropathy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/39/12918\">",
"           Alternative agents in the treatment of idiopathic membranous nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/54/19306\">",
"           Causes and diagnosis of membranous nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/18/34088\">",
"           Membranous nephropathy and renal transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/59/37812\">",
"           Renal disease in patients with rheumatoid arthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/41/37530\">",
"           Treatment of idiopathic membranous nephropathy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Minimal change disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/10/18598\">",
"           Acute kidney injury (acute renal failure) in minimal change disease and other forms of nephrotic syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/50/34601\">",
"           Etiology, clinical features, and diagnosis of minimal change disease in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/47/41717\">",
"           Minimal change variants: Mesangial proliferation; IgM nephropathy; C1q nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/9/31898\">",
"           Treatment of minimal change disease in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Nephrotic syndrome and proteinuria",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/10/18598\">",
"           Acute kidney injury (acute renal failure) in minimal change disease and other forms of nephrotic syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/37/13914\">",
"           Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/5/9304\">",
"           Biology of glomerular podocytes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/51/43829\">",
"           Endocrine dysfunction in the nephrotic syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/3/2104\">",
"           HIV-associated nephropathy (HIVAN)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/41/33430\">",
"           Lipid abnormalities in nephrotic syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/0/24582\">",
"           NSAIDs: Acute kidney injury (acute renal failure) and nephrotic syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/15/17655\">",
"           Orthostatic (postural) proteinuria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/18/32041\">",
"           Overview of heavy proteinuria and the nephrotic syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/10/36008\">",
"           Pathophysiology and treatment of edema in patients with the nephrotic syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/7/28799\">",
"           Patient information: Split urine collection for orthostatic proteinuria (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/12/3273\">",
"           Renal vein thrombosis and hypercoagulable state in nephrotic syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/29/35287\">",
"           Antiphospholipid syndrome and the kidney",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/15/34040\">",
"           Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/31/27130\">",
"           Differential diagnosis and evaluation of glomerular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/11/21690\">",
"           Indications for and complications of renal biopsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/27/1464\">",
"           Lipoprotein glomerulopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/30/18921\">",
"           Mechanisms of immune injury of the glomerulus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/4/4168\">",
"           Overview of kidney disease in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/20/40261\">",
"           Pathogenesis of tissue injury in glomerulonephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/59/37812\">",
"           Renal disease in patients with rheumatoid arthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/27/5556\">",
"           Renal disease in the setting of infective endocarditis or an infected ventriculoatrial shunt",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/61/23512\">",
"           The diffuse alveolar hemorrhage syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/52/36682\">",
"           Treatment of the mixed cryoglobulinemia syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Rapidly progressive glomerulonephritis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/62/17386\">",
"           Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/32/34314\">",
"           Initial immunosuppressive therapy in granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/27/43448\">",
"           Mechanisms of glomerular crescent formation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/30/18921\">",
"           Mechanisms of immune injury of the glomerulus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/51/18231\">",
"           Overview of the classification and treatment of rapidly progressive (crescentic) glomerulonephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/19/4409\">",
"           Pathogenesis and diagnosis of anti-GBM antibody (Goodpasture's) disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/20/40261\">",
"           Pathogenesis of tissue injury in glomerulonephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/27/5556\">",
"           Renal disease in the setting of infective endocarditis or an infected ventriculoatrial shunt",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/61/23512\">",
"           The diffuse alveolar hemorrhage syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/16/7432\">",
"           Treatment of anti-GBM antibody (Goodpasture's) disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Treatment",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/61/32727\">",
"           Alternative agents in the treatment of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/31/6646\">",
"           Complications of therapeutic plasma exchange",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/61/31703\">",
"           Determinants of glucocorticoid dosing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/17/13594\">",
"           Evaluation and treatment of membranoproliferative glomerulonephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/40/16008\">",
"           General principles of the use of cyclophosphamide in rheumatic and renal disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/32/25098\">",
"           General toxicity of cyclophosphamide and chlorambucil in inflammatory diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/37/22103\">",
"           Glucocorticoid withdrawal",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/32/34314\">",
"           Initial immunosuppressive therapy in granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/47/27386\">",
"           Major side effects of systemic glucocorticoids",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/51/18231\">",
"           Overview of the classification and treatment of rapidly progressive (crescentic) glomerulonephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/33/38420\">",
"           Prescription and technique of therapeutic plasma exchange",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/37/37466\">",
"           Therapy of diffuse or focal proliferative lupus nephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/7/42106\">",
"           Treatment and prognosis of IgA nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/16/7432\">",
"           Treatment of anti-GBM antibody (Goodpasture's) disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/15/3321\">",
"           Treatment of cyclophosphamide-resistant granulomatosis with polyangiitis (Wegener���������s) and microscopic polyangiitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/48/40714\">",
"           Treatment of diabetic nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/9/31898\">",
"           Treatment of minimal change disease in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/53/23383\">",
"           Treatment of secondary (AA) amyloidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/52/36682\">",
"           Treatment of the mixed cryoglobulinemia syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Vasculitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/61/32727\">",
"           Alternative agents in the treatment of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/26/9641\">",
"           Clinical manifestations and diagnosis of polyarteritis nodosa",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/28/9674\">",
"           Clinical spectrum of antineutrophil cytoplasmic antibodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/40/16008\">",
"           General principles of the use of cyclophosphamide in rheumatic and renal disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/57/30614\">",
"           Hypersensitivity vasculitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/32/34314\">",
"           Initial immunosuppressive therapy in granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/23/6521\">",
"           Maintenance immunosuppressive therapy in granulomatosis with polyangiitis (Wegener���������s) and microscopic polyangiitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/20/33097\">",
"           Pathogenesis of granulomatosis with polyangiitis (Wegener���������s) and related vasculitides",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/15/24824\">",
"           Patient and renal outcomes in granulomatosis with polyangiitis (Wegener���������s) and microscopic polyangiitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/58/9130\">",
"           Relapsing disease in granulomatosis with polyangiitis (Wegener���������s) and microscopic polyangiitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/54/5993\">",
"           Renal manifestations of Henoch-Sch������nlein purpura",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/29/28119\">",
"           Treatment and prognosis of polyarteritis nodosa",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/15/3321\">",
"           Treatment of cyclophosphamide-resistant granulomatosis with polyangiitis (Wegener���������s) and microscopic polyangiitis",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-4825229079-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f2_42_2721=[""].join("\n");
var outline_f2_42_2721=null;
var title_f2_42_2722="Anaphylaxis action plan";
var content_f2_42_2722=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F60439&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F60439&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 599px\">",
"   <div class=\"ttl\">",
"    Anaphylaxis Emergency Action Plan",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 579px; height: 785px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The American Academy of Allergy, Asthma &amp; Immunology. Copyright &copy; The American Academy of Allergy, Asthma &amp; Immunology (",
"     <a href=\"file://www.aaaai.org\" target=\"_blank\">",
"      www.aaaai.org",
"     </a>",
"     ). Further discussion of the Anaphylaxis Emergency Action Plan is available in: Simons, FER. Killer allergy: long-term management in the community. J Allergy Clin Immunol 2006; 117:367.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2722=[""].join("\n");
var outline_f2_42_2722=null;
var title_f2_42_2723="Patient information: Campylobacter infection (The Basics)";
var content_f2_42_2723=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/87106\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"UTD.htm?0/34/557\">",
"         Tips for safe food handling",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?9/5/9299\">",
"         Patient information: Diarrhea in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/34/34338\">",
"         Patient information: Diarrhea in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?10/22/10595\">",
"         Patient information: Food poisoning (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/57/28562\">",
"         Patient information: Nausea and vomiting in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/13/27858\">",
"         Patient information: Rotavirus infection (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?37/26/38305\">",
"         Patient information: Typhoid fever (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?9/3/9267\">",
"         Patient information: Viral gastroenteritis (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?35/29/36308\">",
"         Patient information: Acute diarrhea in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/1/27\">",
"         Patient information: Acute diarrhea in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?7/14/7395\">",
"         Patient information: Chronic diarrhea in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?28/30/29156\">",
"         Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Campylobacter infection (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H7929152\">",
"      <span class=\"h1\">",
"       What is a Campylobacter infection?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A Campylobacter infection is an infection that causes sudden diarrhea, stomach cramping, and pain in the area around the belly button. It is caused by a type of bacteria called Campylobacter.",
"     </p>",
"     <p>",
"      Campylobacter bacteria are often found in chicken, turkey, and other types of poultry. These bacteria are also found in other types of meat. Most often, people get infected with campylobacter when they:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Eat undercooked chicken or other meats",
"       </li>",
"       <li>",
"        Eat foods that were prepared using knives, cutting boards, or other kitchen tools that were used on raw chicken or meat and were not washed",
"       </li>",
"       <li>",
"        Drink milk that is not pasteurized or eat foods made with milk that is not pasteurized",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7929167\">",
"      <span class=\"h1\">",
"       What are the symptoms of a Campylobacter infection?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Diarrhea that comes on suddenly (and can be bloody)",
"       </li>",
"       <li>",
"        Stomach cramps",
"       </li>",
"       <li>",
"        Pain in the area around the belly button (sometimes spreading to the right side of the belly)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      For about a day before the above symptoms start, a third of those with a Campylobacter infection also get:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        High fever",
"       </li>",
"       <li>",
"        Shaking",
"       </li>",
"       <li>",
"        Body aches",
"       </li>",
"       <li>",
"        Dizziness",
"       </li>",
"       <li>",
"        Confusion",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Diarrhea caused by Campylobacter usually lasts about a week and then goes away on its own. Belly pain sometimes continues even after diarrhea goes away.",
"     </p>",
"     <p>",
"      In very few cases, some people develop pain in their ankles, knees, or other joints after having a Campylobacter infection. This pain usually goes away on its own.",
"     </p>",
"     <p>",
"      In children, the symptoms of Campylobacter infection can be more severe. Children can have the same symptoms listed above, but they can also have vomiting and a higher fever. In children, the fever can even lead to seizures.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7929182\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse if you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Have severe belly pain",
"       </li>",
"       <li>",
"        Cannot eat or drink",
"       </li>",
"       <li>",
"        Vomit blood or have blood in your bowel movements",
"       </li>",
"       <li>",
"        Have a fever higher than 100.4&deg;F (38&deg;C)",
"       </li>",
"       <li>",
"        Have diarrhea that lasts more than a week",
"       </li>",
"       <li>",
"        Have any medical problem that makes it hard for you to fight infection (such as cancer or AIDS) or you take medicines to suppress your immune system",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Young children and older adults with symptoms should make sure to see their doctor or nurse. That&rsquo;s because people in these groups can get dehydrated more easily.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7929197\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Probably not, but your doctor might do a test on a sample of bowel movement to check what type of infection you have.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7929212\">",
"      <span class=\"h1\">",
"       How is Campylobacter infection treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment is not usually needed. Most people get better without treatment.",
"     </p>",
"     <p>",
"      People who are very sick or who do not get better after a week can get antibiotics to fight the infection.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7929227\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Drink enough liquids so that your body does not get &ldquo;dehydrated.&rdquo; Dehydration is when the body loses too much water.",
"       </li>",
"       <li>",
"        Eat small meals that do not have a lot of fat in them",
"       </li>",
"       <li>",
"        Rest, if you feel tired",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <strong>",
"       Can Campylobacter infection be prevented?",
"      </strong>",
"      &mdash; To reduce your chance of getting (or spreading) a Campylobacter infection and other types of food poisoning:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Wash your hands after changing diapers, going to the bathroom, blowing your nose, touching animals, or taking out the trash",
"       </li>",
"       <li>",
"        Stay home from work or school until you feel better (if you are sick)",
"       </li>",
"       <li>",
"        Pay attention to food safety. Tips include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Do not drink unpasteurized milk or foods made with it",
"       </li>",
"       <li>",
"        Wash fruits and vegetables well before eating them",
"       </li>",
"       <li>",
"        Keep the refrigerator colder than 40&deg;F (4.4&deg;C) and the freezer below 0&deg;F (-18&deg;C)",
"       </li>",
"       <li>",
"        Cook meat and seafood until well done",
"       </li>",
"       <li>",
"        Cook eggs until the yolk is firm",
"       </li>",
"       <li>",
"        Always wash your hands, knives, and cutting boards after they touch raw food",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      For more food safety tips to prevent food poisoning, see the Table (",
"      <a class=\"graphic graphic_table graphicRef60529 \" href=\"UTD.htm?0/34/557\">",
"       table 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      Pregnant women and people who have trouble fighting infection can do more things to prevent getting food poisoning. If you are pregnant or have trouble fighting off infections, talk to your doctor or nurse about other ways to prevent getting food poisoning.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7929259\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/22/10595?source=see_link\">",
"       Patient information: Food poisoning (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/5/9299?source=see_link\">",
"       Patient information: Diarrhea in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/34/34338?source=see_link\">",
"       Patient information: Diarrhea in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/57/28562?source=see_link\">",
"       Patient information: Nausea and vomiting in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/3/9267?source=see_link\">",
"       Patient information: Viral gastroenteritis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/13/27858?source=see_link\">",
"       Patient information: Rotavirus infection (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/26/38305?source=see_link\">",
"       Patient information: Typhoid fever (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/30/29156?source=see_link\">",
"       Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/29/36308?source=see_link\">",
"       Patient information: Acute diarrhea in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=see_link\">",
"       Patient information: Acute diarrhea in children (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/14/7395?source=see_link\">",
"       Patient information: Chronic diarrhea in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?2/42/2723?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 87106 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-684EC2BD62-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2723=[""].join("\n");
var outline_f2_42_2723=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7929152\">",
"      What is a Campylobacter infection?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7929167\">",
"      What are the symptoms of a Campylobacter infection?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7929182\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7929197\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7929212\">",
"      How is Campylobacter infection treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7929227\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7929259\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/87106\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/34/557\">",
"      Tips for safe food handling",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/29/36308?source=related_link\">",
"      Patient information: Acute diarrhea in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=related_link\">",
"      Patient information: Acute diarrhea in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/14/7395?source=related_link\">",
"      Patient information: Chronic diarrhea in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/5/9299?source=related_link\">",
"      Patient information: Diarrhea in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/34/34338?source=related_link\">",
"      Patient information: Diarrhea in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/22/10595?source=related_link\">",
"      Patient information: Food poisoning (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/30/29156?source=related_link\">",
"      Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/57/28562?source=related_link\">",
"      Patient information: Nausea and vomiting in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/13/27858?source=related_link\">",
"      Patient information: Rotavirus infection (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/26/38305?source=related_link\">",
"      Patient information: Typhoid fever (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/3/9267?source=related_link\">",
"      Patient information: Viral gastroenteritis (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_42_2724="Classic juvenile pityriasis rubra pilaris - Legs";
var content_f2_42_2724=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87153&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87153&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Classic juvenile pityriasis rubra pilaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hyperkeratotic red to orange follicular papules and plaques are on the legs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2724=[""].join("\n");
var outline_f2_42_2724=null;
var title_f2_42_2725="Construction of an ileostomy - segment through abdominal wall";
var content_f2_42_2725=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F78707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F78707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Construction of an ileostomy - segment through abdominal wall",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 447px; height: 680px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts pulling the proximal end of the ileum through the abdonimal wall to construct an ileostomy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2725=[""].join("\n");
var outline_f2_42_2725=null;
var title_f2_42_2726="Benazepril: Patient drug information";
var content_f2_42_2726=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Benazepril: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/19/16696?source=see_link\">",
"     see \"Benazepril: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/5/40023?source=see_link\">",
"     see \"Benazepril: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F139577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lotensin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F139578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Lotensin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10030766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10030768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692146",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may be given to you for other reasons. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10030767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701595",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to benazepril or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4231494",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have ever had a very bad reaction called angioedema. Signs may be swelling of the hands, face, lips, eyes, tongue, or throat; trouble breathing; trouble swallowing; unusual hoarseness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3915366",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes) and are taking aliskiren.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4231030",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease and are taking aliskiren.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701072",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are on a low-salt or salt-free diet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4194403",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This is not a list of all drugs or health problems that interact with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4194405",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take this drug with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10030772\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2858939",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid driving and doing other tasks or actions that call for you to be alert until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4201327",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To lower the chance of feeling dizzy or passing out, rise slowly over a few minutes when sitting or lying down. Be careful climbing stairs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697207",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), this drug may sometimes raise blood sugar. Talk with your doctor about how to fine tune this.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a salt substitute that has potassium, potassium-sparing diuretics, or potassium, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4231042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before you drink wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4194393",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may not work as well in black patients. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4194392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The chance of a very bad or sometimes deadly reaction called angioedema may be higher in black patients. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10030773\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4186184",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor if any of these side effects or any other side effects bother you:",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698017",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10030775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4186185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these side effects:",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699103",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unable to pass urine or change in the amount of urine passed.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698348",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Slow heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4186197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A heartbeat that does not feel normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4193665",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shortness of breath, a big weight gain, swelling in the arms or legs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2699690",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects at",
"       <a href=\"file://www.fda.gov/medwatch\" target=\"_blank\">",
"        file://www.fda.gov/medwatch",
"       </a>",
"       .",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2699689",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may report side effects to Health Canada's Canada Vigilance Program at 1-866-234-2345.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10030770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696083",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use this drug as ordered by your doctor. Read and follow the dosing on the label closely.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble swallowing, talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10030771\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10030776\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4194563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check with your pharmacist about how to throw out unused drugs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10030777\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11584 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.25.216.6-C9F66847B9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2726=[""].join("\n");
var outline_f2_42_2726=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139577\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139578\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030766\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030768\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030767\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030772\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030773\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030775\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030770\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030771\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030776\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030777\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?16/19/16696?source=related_link\">",
"      Benazepril: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/5/40023?source=related_link\">",
"      Benazepril: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_42_2727="Iliac aneurysm symptoms";
var content_f2_42_2727=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F50540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F50540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 555px\">",
"   <div class=\"ttl\">",
"    Iliac aneurysm symptoms",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 535px; height: 585px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Iliac artery aneurysms behave similar to abdominal aortic aneurysms with symptoms related to aneurysm expansion including pain from arterial wall stretching, or compression and erosion of surrounding structures. Compressive symptoms of iliac artery aneurysm can involve the lower urinary tract (eg, ureteric colic, ureteral obstruction, pyelonephritis, urinary retention), lower gastrointestinal tract (eg, pain with defecation, tenesmus and constipation), or lumbar/pelvic nerves (paresthesia, sciatic neuralgia).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2727=[""].join("\n");
var outline_f2_42_2727=null;
var title_f2_42_2728="Nasogastric tube placement";
var content_f2_42_2728=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F76398&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F76398&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 520px\">",
"   <div class=\"ttl\">",
"    Nasogastric tube placement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 500px; height: 581px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Lubricate the nasogastric (NG) tube and offer the patient a cup or glass of water with a straw (unless contraindicated). Place the tube into one of the nares, gently advance the tube but stop before it reaches the nasopharynx. Direct the patient to sip and swallow as the tube is advanced which helps pass the tube into the esophagus. If water is not being used, ask the patient to swallow.",
"    <br>",
"     (B) Once the tube is in place, aspirate using a suction tip syringe and examine the aspirate. It should have a typical gastric fluid appearance (grassy green, clear and colorless with mucus shreds, or brown). If needed, place a small amount on the pH test strip; the pH should be &le;5.0. Alternatively, instill about 15-20 cc warm water and then aspirate. If the tube is in good position, at least 1/2 of the fluid should be returned.",
"     <br>",
"      (C) Secure the NG tube to the patient's nose with hypoallergenic tape (or an NG tube holder). If the patient's skin is oily, wipe the bridge of the nose with an alcohol pad and allow to dry. Split one end of the tape up the center about 1 1/2 inches. Make tabs on the split ends (by folding the sticky sides together). Apply the unsplit tape end on the patient's nose so the split in the tape starts about 1/2 to 1 1/2 inches from the tip of the nose. Crisscross the tabbed ends around the tube. Apply another piece of tape over the bridge of the nose to secure the tube.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced with permission from: Springhouse. Lippincott's Visual Encyclopedia of Clinical Skills. Philadelphia: Wolters Kluwer Health, 2009. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2728=[""].join("\n");
var outline_f2_42_2728=null;
var title_f2_42_2729="Evaluation of hypertension in children and adolescents";
var content_f2_42_2729=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of hypertension in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/42/2729/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/42/2729/contributors\">",
"     Tej K Mattoo, MD, DCH, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/42/2729/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/42/2729/contributors\">",
"     Patrick Niaudet, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/42/2729/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/42/2729/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/42/2729/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has become clear that hypertension (HTN) begins in childhood and adolescence and that it contributes to the early development of cardiovascular disease (CVD). The supporting data include clinical studies that demonstrate cardiovascular structural and functional changes in children with HTN and autopsy studies that have shown an association of BP with atherosclerotic changes in the aorta and heart in children and young adults. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/45/17113?source=see_link\">",
"     \"Definition and diagnosis of hypertension in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/5/43096?source=see_link&amp;anchor=H6#H6\">",
"     \"Risk factors and development of atherosclerosis in childhood\", section on 'Hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In hypertensive adults, multiple randomized trials have shown that reduction of BP by antihypertensive therapy reduces cardiovascular morbidity and mortality. The magnitude of the benefit increases with the severity of the HTN. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4169?source=see_link\">",
"     \"Hypertension: Who should be treated?\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Based upon these observations, identifying children with HTN and successfully treating their HTN should have an important impact on long-term outcomes of CVD. One of the most important components of the successful management of childhood HTN is determining whether or not there is an underlying cause that is amenable to treatment.",
"   </p>",
"   <p>",
"    The evaluation of children with HTN will be reviewed here. The epidemiology, etiology, diagnosis, and treatment of childhood hypertension are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/7/42105?source=see_link\">",
"     \"Epidemiology, risk factors, and etiology of hypertension in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/45/17113?source=see_link\">",
"     \"Definition and diagnosis of hypertension in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27626?source=see_link\">",
"     \"Treatment of hypertension in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, the evaluation for hypertensive emergency is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/53/17241?source=see_link\">",
"     \"Approach to hypertensive emergencies and urgencies in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children, the following definitions based upon the 2004 National High Blood Pressure Education Program Working Group (NHBPEP) are used to classify BP measurements in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/1\">",
"     1",
"    </a>",
"    ]. BP percentiles are based upon gender, age, and height (",
"    <a class=\"graphic graphic_table graphicRef63856 \" href=\"UTD.htm?7/45/7894\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef52646 \" href=\"UTD.htm?7/46/7910\">",
"     table 2",
"    </a>",
"    ). The systolic and diastolic BP are of equal importance; if there is a disparity between the two, the higher value determines the BP category. The age- and height-specific blood pressure percentiles may be determined using calculators for boys (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?9/15/9463?source=see_link\">",
"     calculator 1",
"    </a>",
"    ) or for girls (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?9/33/9751?source=see_link\">",
"     calculator 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/45/17113?source=see_link\">",
"     \"Definition and diagnosis of hypertension in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normal BP &ndash; Both systolic and diastolic BP &lt;90",
"      <sup>",
"       th",
"      </sup>",
"      percentile.",
"     </li>",
"     <li>",
"      Prehypertension &ndash; Systolic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      diastolic BP &ge;90",
"      <sup>",
"       th",
"      </sup>",
"      percentile but &lt;95",
"      <sup>",
"       th",
"      </sup>",
"      percentile",
"      <strong>",
"       or",
"      </strong>",
"      if BP exceeds",
"      <span class=\"nowrap\">",
"       120/80",
"      </span>",
"      mmHg (even if &lt;90",
"      <sup>",
"       th",
"      </sup>",
"      percentile for age, gender, and height).",
"     </li>",
"     <li>",
"      Hypertension &ndash; HTN is defined as either systolic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      diastolic BP &ge;95",
"      <sup>",
"       th",
"      </sup>",
"      percentile measured upon three or more separate occasions. The degree of HTN is further delineated by the two following stages.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <strong>",
"       Stage 1",
"      </strong>",
"      HTN &ndash; Systolic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      diastolic BP between the 95",
"      <sup>",
"       th",
"      </sup>",
"      percentile and 5 mmHg above the 99",
"      <sup>",
"       th",
"      </sup>",
"      percentile.",
"     </li>",
"     <li>",
"      <strong>",
"       Stage 2",
"      </strong>",
"      HTN &ndash; Systolic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      diastolic BP &ge;99",
"      <sup>",
"       th",
"      </sup>",
"      percentile plus 5 mmHg.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of the initial evaluation of the hypertensive child or adolescent are to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identify secondary HTN (ie, an underlying cause of hypertension), which may be cured, avoiding the need for prolonged drug therapy (",
"      <a class=\"graphic graphic_table graphicRef73738 \" href=\"UTD.htm?27/60/28621\">",
"       table 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Identify other comorbid risk factors (eg, obesity and dyslipidemia) for cardiovascular disease (CVD) or diseases associated with an increased risk for CVD (eg, diabetes mellitus). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/5/43096?source=see_link\">",
"       \"Risk factors and development of atherosclerosis in childhood\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/15/40184?source=see_link\">",
"       \"Diseases associated with atherosclerosis in childhood\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Identify children who should be treated with antihypertensive drug therapy. Indications for pharmacologic therapy are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27626?source=see_link&amp;anchor=H14#H14\">",
"       \"Treatment of hypertension in children and adolescents\", section on 'Whom to treat'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most hypertensive children, particularly those who are likely to have secondary HTN, should be referred to a pediatric nephrologist or other physician with experience in childhood HTN.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Primary versus secondary hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;An important initial step in the assessment of hypertensive children is distinguishing between primary (without an identifiable cause) and secondary HTN. Correction of the underlying disorder may cure the HTN in children with secondary causes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/7/42105?source=see_link&amp;anchor=H13#H13\">",
"     \"Epidemiology, risk factors, and etiology of hypertension in children and adolescents\", section on 'Etiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following factors can help differentiate secondary from primary HTN:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prepubertal children generally have some form of secondary HTN while adolescents and postpubertal children usually have primary HTN [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/2,3\">",
"       2,3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Severe HTN (defined as stage 2 HTN) is usually associated with secondary HTN, while primary HTN is associated with mild or stage 1 HTN. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diastolic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      nocturnal HTN detected by ambulatory BP monitoring is more likely to be associated with secondary HTN than primary HTN [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/3-5\">",
"       3-5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Primary HTN is associated with overweight",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a positive family history of HTN. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/7/42105?source=see_link&amp;anchor=H14#H14\">",
"       \"Epidemiology, risk factors, and etiology of hypertension in children and adolescents\", section on 'Primary hypertension'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Symptoms or signs suggestive of an underlying disorder indicate secondary HTN. As an example, symptoms of sympathetic overactivity (catecholamine excess), such as tachycardia and flushing, raise the possibility of pheochromocytoma, while edema, elevations in serum creatinine,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      an abnormal urinalysis are consistent with underlying renal disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/7/42105?source=see_link&amp;anchor=H15#H15\">",
"       \"Epidemiology, risk factors, and etiology of hypertension in children and adolescents\", section on 'Secondary hypertension'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Comorbid risk factors and diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;HTN is one of several risk factors that increase the risk of premature atherosclerosis in childhood and of cardiovascular disease (CVD) in adults. These risk factors (eg, HTN,",
"    <span class=\"nowrap\">",
"     overweight/obesity,",
"    </span>",
"    dyslipidemia, and a family history of premature CVD) do not generally occur in isolation but are usually found concurrently, which further increases the likelihood of premature atherosclerosis and CVD. In addition, several childhood diseases such as type 1 and type 2 diabetes mellitus, and chronic kidney disease are associated with accelerated atherosclerosis and CVD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/5/43096?source=see_link&amp;anchor=H3#H3\">",
"     \"Risk factors and development of atherosclerosis in childhood\", section on 'Risk factors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/15/40184?source=see_link\">",
"     \"Diseases associated with atherosclerosis in childhood\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Current recommendations by the National High Blood Pressure Education Program Working Group (NHBPEP) are to target BP goals below the 90",
"    <sup>",
"     th",
"    </sup>",
"    percentile for age, height, and gender in children and adolescents with one or more of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Presence of other CVD risk factors (ie,",
"      <span class=\"nowrap\">",
"       overweight/obesity,",
"      </span>",
"      family history of premature CVD, or dyslipidemia).",
"     </li>",
"     <li>",
"      Evidence of target-organ damage (eg, left ventricular hypertrophy, proteinuria, renal scarring, or retinopathy).",
"     </li>",
"     <li>",
"      Diseases with high risk of early atherosclerosis (eg, type 1 and 2 diabetes mellitus, chronic kidney disease, and Kawasaki disease).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of another CVD risk factor or disease associated with a high-risk of CVD may impact on the timing and choice of intervention. As a result, the evaluation of childhood HTN needs to systematically identify the presence of these factors and diseases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27626?source=see_link\">",
"     \"Treatment of hypertension in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INITIAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation of the child with HTN includes history, physical examination, and laboratory tests and procedures. It is, as discussed above, primarily focused upon the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Differentiate primary from secondary HTN by looking for signs and symptoms that are associated with specific underlying etiologies for HTN (",
"      <a class=\"graphic graphic_table graphicRef76420 \" href=\"UTD.htm?30/40/31372\">",
"       table 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef76824 \" href=\"UTD.htm?31/61/32733\">",
"       table 5",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Identify comorbid CVD risk factors or diseases associated with a risk of CVD.",
"     </li>",
"     <li>",
"      Identify patients with stage 2 HTN (",
"      <a class=\"graphic graphic_table graphicRef63856 \" href=\"UTD.htm?7/45/7894\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef52646 \" href=\"UTD.htm?7/46/7910\">",
"       table 2",
"      </a>",
"      ) or with evidence of end-organ injury so that pharmacologic therapy can be initiated. The age- and height-specific blood pressure percentiles may be determined using calculators for boys (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?9/15/9463?source=see_link\">",
"       calculator 1",
"      </a>",
"      ) or for girls (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?9/33/9751?source=see_link\">",
"       calculator 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27626?source=see_link&amp;anchor=H14#H14\">",
"       \"Treatment of hypertension in children and adolescents\", section on 'Whom to treat'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     History and physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms consistent with hypertensive emergencies include headache, seizures, changes in mental status, focal neurologic complaints, visual disturbances, and cardiovascular complaints indicative of heart failure (such as chest pain, palpitations, cough, or shortness of breath). These children require emergent evaluation and treatment.",
"   </p>",
"   <p>",
"    The blood pressure should be accurately measured and the severity of HTN should be determined. Pharmacologic therapy should be initiated without delay in children with stage 2 HTN or those who may have a hypertensive emergency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/45/17113?source=see_link&amp;anchor=H11#H11\">",
"     \"Definition and diagnosis of hypertension in children and adolescents\", section on 'Measurement of blood pressure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27626?source=see_link&amp;anchor=H14#H14\">",
"     \"Treatment of hypertension in children and adolescents\", section on 'Whom to treat'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Secondary versus primary hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secondary hypertension should be suspected in children with one or more of the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prepubertal, particularly younger than 10 years of age.",
"     </li>",
"     <li>",
"      A thin child with a negative family history for HTN. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/7/42105?source=see_link&amp;anchor=H5#H5\">",
"       \"Epidemiology, risk factors, and etiology of hypertension in children and adolescents\", section on 'Obesity'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/7/42105?source=see_link&amp;anchor=H8#H8\">",
"       \"Epidemiology, risk factors, and etiology of hypertension in children and adolescents\", section on 'Genetics'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An acute rise in BP above a previously stable baseline.",
"     </li>",
"     <li>",
"      Severe HTN defined as stage 2 HTN (BP &gt;5 mmHg above the 99",
"      <sup>",
"       th",
"      </sup>",
"      percentile) (",
"      <a class=\"graphic graphic_table graphicRef63856 \" href=\"UTD.htm?7/45/7894\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef52646 \" href=\"UTD.htm?7/46/7910\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above.) The age- and height-specific blood pressure percentiles may be determined using calculators for boys (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?9/15/9463?source=see_link\">",
"       calculator 1",
"      </a>",
"      ) or for girls (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?9/33/9751?source=see_link\">",
"       calculator 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Stage 1 HTN (BP &ge;95",
"      <sup>",
"       th",
"      </sup>",
"      percentile but less than stage 2) with finding(s) on history or physical examination that suggests systemic disease or a specific secondary etiology of HTN. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/7/42105?source=see_link&amp;anchor=H15#H15\">",
"       \"Epidemiology, risk factors, and etiology of hypertension in children and adolescents\", section on 'Secondary hypertension'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Specific ambulatory blood pressure patterns, such as sustained diastolic hypertension, nocturnal hypertension,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      blunted nocturnal dipping. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/21/25943?source=see_link\">",
"       \"Ambulatory blood pressure monitoring in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Past history of urinary tract infection, especially pyelonephritis, or underlying congenital kidney or urologic anomalies raises the possibility of renal scarring.",
"     </li>",
"     <li>",
"      Symptoms suggestive of catecholamine excess include headache, sweating, and tachycardia in addition to HTN. Pheochromocytoma, neuroblastoma, or use of sympathomimetic drugs including phenylpropanolamine (over-the-counter decongestant), cocaine, amphetamines, phencyclidine, epinephrine,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/46/41696?source=see_link\">",
"       phenylephrine",
"      </a>",
"      , and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/51/25397?source=see_link\">",
"       terbutaline",
"      </a>",
"      , and the combination of a monoamine oxidase (MAO) inhibitor plus ingestion of tyramine-containing foods are possible etiologies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/14/38121?source=see_link\">",
"       \"Pheochromocytoma in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15609?source=see_link\">",
"       \"Clinical presentation, diagnosis, and staging evaluation of neuroblastoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ambiguous genitalia may be suggestive of congenital adrenal hyperplasia with excess endogenous secretion of androgens and mineralocorticoids. Children with mineralocorticoid excess may develop hypokalemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24506?source=see_link\">",
"       \"Evaluation of the infant with ambiguous genitalia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Edema and hematuria may be indicative of renal parenchymal disease. Initial laboratory testing demonstrating an abnormal urinalysis or elevated serum creatinine add further support for an intrinsic renal disease process. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Laboratory evaluation'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Patients with glomerulonephritis due to systemic disorders such as Henoch-Sch&ouml;nlein purpura (IgA vasculitis) or systemic lupus erythematosus have other clinical findings including arthritis, rash, and abdominal pain (the latter especially in Henoch-Sch&ouml;nlein purpura). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/49/40729?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10810?source=see_link\">",
"       \"Systemic lupus erythematosus in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A family history of chronic or congenital renal disease (such as polycystic kidney disease), or other genetic conditions that are associated with HTN, such as neurofibromatosis or tuberous sclerosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=see_link\">",
"       \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/18/43303?source=see_link&amp;anchor=H2#H2\">",
"       \"Renal manifestations of tuberous sclerosis and renal angiomyolipoma\", section on 'Tuberous sclerosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Medication history (eg, glucocorticoids, anabolic steroids, or oral contraceptives).",
"     </li>",
"     <li>",
"      History of umbilical arterial catheterization (UAC) as a neonate. UAC is a predisposing factor for renovascular disease.",
"     </li>",
"     <li>",
"      The presence of an abdominal bruit raises the possibility of renovascular disease, but its absence does not exclude the diagnosis.",
"     </li>",
"     <li>",
"      The findings of hypertension in the upper extremities and low or unobtainable blood pressure in the lower extremities, significant difference between right and left arm BP, and diminished or delayed femoral pulses are suggestive of coarctation of the aorta, the primary cardiac cause of hypertension. The diagnosis is confirmed by echocardiogram. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link\">",
"       \"Clinical manifestations and diagnosis of coarctation of the aorta\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     CVD risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history and physical examination should assess for other cardiovascular disease (CVD) risk factors or diseases associated with CVD in addition to hypertension.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Family history of premature CVD",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      strokes.",
"     </li>",
"     <li>",
"      Identify overweight and obese children by calculating body mass index (BMI) defined as the weight in kg divided by height in m2. BMI and BMI percentiles may be determined using calculators for boys (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?35/14/36070?source=see_link\">",
"       calculator 3",
"      </a>",
"      ) or for girls (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?34/60/35782?source=see_link\">",
"       calculator 4",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      Weight classes based upon BMI are as follows (",
"      <a class=\"graphic graphic_figure graphicRef65305 \" href=\"UTD.htm?12/3/12351\">",
"       figure 1",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Normal: BMI less than 25",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"     </li>",
"     <li>",
"      Overweight: BMI between 25 to 29.9",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"     </li>",
"     <li>",
"      Obese: BMI between 30 to 39.9",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"     </li>",
"     <li>",
"      Markedly obese: BMI greater than 40",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      History of smoking.",
"     </li>",
"     <li>",
"      History of type 1 or 2 diabetes mellitus, chronic kidney disease, organ transplantation, cardiac disease, Kawasaki disease, autoimmune disease, familial hypercholesterolemia, and cancer. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/15/40184?source=see_link\">",
"       \"Diseases associated with atherosclerosis in childhood\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      History of sleep disorders. Sleeping disorders, especially sleep apnea, are associated with HTN and CVD in adults. In children, data also suggest an association between sleep-disordered breathing and HTN [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/6-9\">",
"       6-9",
"      </a>",
"      ]. Based upon this information, the NHBPEP Working Group recommends that a sleep history should be obtained in a child with HTN, especially if he or she is overweight. If a history of either sleep apnea or loud and frequent snoring is obtained, polysomnography should be considered to identify a sleep disorder [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/1\">",
"       1",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=see_link\">",
"       \"Evaluation of suspected obstructive sleep apnea in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Evidence of target-organ damage",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination should include a retinal examination to detect any retinal vascular changes due to HTN (",
"    <a class=\"graphic graphic_picture graphicRef67621 graphicRef78225 graphicRef57183 \" href=\"UTD.htm?6/56/7047\">",
"     picture 1A-C",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/22/21859?source=see_link\">",
"     \"Ocular effects of hypertension\"",
"    </a>",
"    .) Cardiac heave or laterally displaced PMI may indicate left ventricular hypertrophy (LVH).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Laboratory evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial laboratory evaluation in all children with persistent HTN is directed at determining the etiology of HTN, identifying other CVD risk factors, and detecting target-organ damage [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/1\">",
"     1",
"    </a>",
"    ]. The following approach is recommended by the 2004 National High Blood Pressure Education Program Working Group (NHBPEP):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Measurement of serum BUN, creatinine, and electrolytes, and collection of urine for urinalysis. These tests permit quick assessment of renal function and abnormalities in glucose (eg, diabetes mellitus) or potassium homeostasis (eg, chronic kidney disease or congenital adrenal hyperplasia). An abnormal urinalysis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      an elevation in serum creatinine are suggestive of underlying renal disease.",
"     </li>",
"     <li>",
"      Complete blood count, looking for anemia that may reflect chronic diseases such as vasculitis and chronic kidney disease.",
"     </li>",
"     <li>",
"      Measurement of fasting plasma glucose and lipids to identify children with diabetes mellitus and dyslipidemia. These tests should also be performed in prehypertensive children who are obese, have a family history of premature CVD, or have chronic kidney disease.",
"     </li>",
"     <li>",
"      An echocardiogram to identify children with left ventricular hypertrophy (LVH) because clinical parameters, such as the severity of HTN, and electrocardiography do not accurately predict LVH [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. LVH is the most prominent manifestation of target-organ damage from HTN [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/1\">",
"       1",
"      </a>",
"      ]. LVH has been reported in 30 to 40 percent of children and adolescents with HTN [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/10,12-16\">",
"       10,12-16",
"      </a>",
"      ] and if present, is an indication to initiate or intensify antihypertensive therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/17\">",
"       17",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Echocardiography should also be performed in prehypertensive children with obesity, hyperlipidemia, diabetes mellitus, or chronic kidney disease. Of note, left ventricular mass increases with higher BMI, and in the general pediatric population in the United States, LVM appears to be rising due to higher BMI. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=see_link&amp;anchor=H9#H9\">",
"       \"Comorbidities and complications of obesity in children and adolescents\", section on 'Cardiovascular'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Renal ultrasonography is used to determine the presence of both kidneys and presence of any other congenital anomaly, or disparate renal size.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     FURTHER EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon the initial history, physical examination, and laboratory evaluation, the clinician should be able to establish whether the HTN is primary or secondary. This distinction will determine whether further evaluation is performed for a potentially reversible cause of secondary HTN.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Primary hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertensive children who fit the primary HTN profile may need no further laboratory evaluation beyond the initial testing cited above [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The NHBPEP recommends renal ultrasonography for all hypertensive children and adolescents. Although we continue to obtain renal ultrasounds in all our patients with HTN, other institutions do not routinely perform this study in patients who strongly fit the profile of primary HTN defined as a post-pubertal adolescent who has stage 1 HTN, is",
"    <span class=\"nowrap\">",
"     overweight/obese,",
"    </span>",
"    has a strong family history of primary HTN, and has no sign or symptom suggestive of secondary HTN after completion of the initial evaluation.",
"   </p>",
"   <p>",
"    Among obese children with primary HTN, measurement of hemoglobin A1c may be indicated, particularly if there is a strong family history of type 2 diabetes mellitus.",
"   </p>",
"   <p>",
"    There are little data on the usefulness of plasma levels of uric acid, homocysteine, and lipoprotein(a) in the evaluation of pediatric primary HTN. Elevation of these substances has been reported to be associated with an increased risk of cardiovascular disease in adults. The NHBPEP does not recommend these studies unless there is a strong family history of an abnormality [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/1,18\">",
"     1,18",
"    </a>",
"    ]. (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/19/40248?source=see_link\">",
"     \"Lipoprotein(a) and cardiovascular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/26/422?source=see_link&amp;anchor=H13#H13\">",
"     \"Initial evaluation of the hypertensive adult\", section on 'Assessment of cardiovascular risk'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/37/34394?source=see_link&amp;anchor=H1265380#H1265380\">",
"     \"Overview of the possible risk factors for cardiovascular disease\", section on 'Uric acid'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/37/34394?source=see_link&amp;anchor=H1268156#H1268156\">",
"     \"Overview of the possible risk factors for cardiovascular disease\", section on 'Vitamins, antioxidants and homocysteine'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Secondary hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Further evaluation is required in patients with findings suggestive of secondary HTN to determine the underlying cause. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Secondary versus primary hypertension'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The following diagnostic studies may be performed in hypertensive children with a high degree of suspicion that an underlying disorder is present [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Renal imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed previously, renal ultrasound is useful to determine the presence of both kidneys or presence of any congenital anomaly, or disparate renal size. The NHBPEP recommends renal ultrasonography for all hypertensive children and adolescents. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Primary hypertension'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In patients with a strong suspicion for renal scarring from the history or with a suggestive but indeterminant finding on renal ultrasound, a 99mTc&ndash;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/22/8548?source=see_link\">",
"     dimercaptosuccinic acid",
"    </a>",
"    (DMSA) renal scan can be performed, since it is a more sensitive study to detect renal cortical loss and scarring [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Plasma renin activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma renin activity (PRA) may be useful in patients suspected to have one of the following conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Excess mineralocorticoids (eg, aldosterone) secretion &ndash; Patients with mineralocorticoid excess are usually hypokalemic, have metabolic alkalosis, and their PRA is low and often unmeasurable. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37911?source=see_link\">",
"       \"Clinical features of primary aldosteronism\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Congenital adrenal hyperplasia is a frequent cause of excess mineralocorticoid secretion in children. Affected patients may also present as a neonate with ambiguous genitalia due to the excess secretion of androgens. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/52/23369?source=see_link&amp;anchor=H11#H11\">",
"       \"Causes and clinical manifestations of primary adrenal insufficiency in children\", section on 'Congenital adrenal hyperplasia'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24506?source=see_link\">",
"       \"Evaluation of the infant with ambiguous genitalia\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Aldosterone-secreting tumors are rare in children. Primary hypersecretion of aldosterone may also result from the rare genetic disorder glucocorticoid-remediable hyperaldosteronism. Hypokalemia is absent in more than one-half of these patients. In the absence of hypokalemia at presentation, the diagnosis may be suspected from the family history of early HTN (before age 21 years) and the frequent development of marked hypokalemia after the administration of a thiazide diuretic. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/5/22615?source=see_link\">",
"       \"Familial hyperaldosteronism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Renin-secreting tumor &ndash; Renin-secreting tumors are rare both in children and adults. Patients generally present with severe HTN, hypokalemia, metabolic alkalosis, and markedly elevated renin levels [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Renovascular disease &ndash; The plasma renin activity may be elevated in children with renovascular HTN but, as is true in adults, it is a relatively insensitive test. Approximately 15 percent of children with arteriographically evident renal artery stenosis have normal plasma renin activity [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2729/abstract/22,23\">",
"       22,23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Plasma and urine catecholamines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with HTN due to disorders with catecholamine excess such as pheochromocytoma and neuroblastoma will have elevated levels of both plasma and urine catecholamines and metabolites. In addition to HTN, affected patients may present with headache, sweating, and tachycardia. In patients with symptoms of catecholamine excess and elevated plasma and urine catecholamines, further evaluation is required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/14/38121?source=see_link\">",
"     \"Pheochromocytoma in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15609?source=see_link\">",
"     \"Clinical presentation, diagnosis, and staging evaluation of neuroblastoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Renovascular imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our practice, renovascular imaging is considered, especially when infants and children have known predisposing factors or findings associated with renal artery stenosis such as prior umbilical artery catheter placements, family history or findings for neurofibromatosis, an abdominal bruit, or a significant size discrepancy on renal ultrasonography. In addition, we consider renovascular imaging in patients with stage 2 HTN when no other cause has been identified since, as noted above, children with renovascular disease typically have markedly elevated BP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/7/42105?source=see_link&amp;anchor=H17#H17\">",
"     \"Epidemiology, risk factors, and etiology of hypertension in children and adolescents\", section on 'Renovascular disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Standard intraarterial angiography is the current gold standard for evaluating renovascular disease in children. In adults, the following noninvasive tests are used to screen for renal vascular diseases:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Magnetic resonance angiography (MRA)",
"     </li>",
"     <li>",
"      Computed tomographic angiography (CTA)",
"     </li>",
"     <li>",
"      Duplex Doppler ultrasonography",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In children, these procedures are not universally available. In addition, there are considerations that must be taken in account when these tests are performed in small children and infants.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The need for conscious sedation or general anesthesia when performing MRA.",
"     </li>",
"     <li>",
"      The need to modify CT dosing to minimize unnecessary radiation exposures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If renovascular evaluation is required, a radiological center with pediatric experience in these screening techniques should be chosen. The selection of the screening modality is dependent upon the expertise of the clinical staff and the availability of appropriate equipment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/17/31001?source=see_link\">",
"     \"Establishing the diagnosis of renovascular hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Our approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our practice, the initial evaluation includes measurement of serum BUN, creatinine, electrolytes, a complete blood count, urinalysis, renal ultrasonography (unless done previously), and an echocardiogram to evaluate left ventricular mass. Other studies are performed based upon the likelihood that the cause of HTN is secondary. Thus, more extensive evaluation is reserved for prepubertal children (usually less than 10 years of age), and those with stage 2 HTN",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    findings indicative of a specific underlying cause:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plasma renin and aldosterone are obtained in all prepubertal children, any patient with stage 2 HTN, and any patient with hypokalemia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      metabolic alkalosis.",
"     </li>",
"     <li>",
"      Plasma and urine catecholamines are obtained in patients who exhibit symptoms of catecholamine excess (eg, headache, sweating,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tachycardia) or are at risk of pheochromocytoma, such as in patients with neurofibromatosis.",
"     </li>",
"     <li>",
"      Screening for renovascular disease is performed in any patient with stage 2 HTN if no other cause is identified, or if there are predisposing risk factors (eg, prior umbilical artery catheterization, neurofibromatosis, or abdominal bruit).",
"     </li>",
"     <li>",
"      A 99mTc-",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/22/8548?source=see_link\">",
"       dimercaptosuccinic acid",
"      </a>",
"      (DMSA) renal scan is performed in patients with a strong suspicion for renal scarring based upon the history (ie, recurrent urinary tract infection) and who have a normal renal ultrasound. A DMSA scan is also obtained to clarify or confirm a suggestive but indeterminant finding on renal ultrasound. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Renal imaging'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (See",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/37/30290?source=see_link\">",
"       \"Patient information: High blood pressure in children (The Basics)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Beyond the Basics topics (See",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?37/28/38337?source=see_link\">",
"       \"Patient information: High blood pressure in children (Beyond the Basics)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypertension (HTN) in childhood and adolescence contributes to premature atherosclerosis and the early development of cardiovascular disease (CVD). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/5/43096?source=see_link&amp;anchor=H6#H6\">",
"       \"Risk factors and development of atherosclerosis in childhood\", section on 'Hypertension'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Childhood HTN is divided into two categories: primary HTN (no identifiable cause is found), and secondary HTN (an underlying cause is identified).",
"     </li>",
"     <li>",
"      The goals of the initial evaluation of a child or adolescent with HTN include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Identify the child with secondary HTN who may have a curable disease (",
"      <a class=\"graphic graphic_table graphicRef73738 \" href=\"UTD.htm?27/60/28621\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Secondary versus primary hypertension'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Secondary hypertension'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Identify other comorbid risk factors (eg, obesity and dyslipidemia) for cardiovascular disease (CVD) or diseases associated with an increased risk for CVD (eg, diabetes mellitus). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/5/43096?source=see_link\">",
"       \"Risk factors and development of atherosclerosis in childhood\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Identify children who should be treated with antihypertensive drug therapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27626?source=see_link&amp;anchor=H14#H14\">",
"       \"Treatment of hypertension in children and adolescents\", section on 'Whom to treat'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most hypertensive children, particularly those who are likely to have secondary HTN, should be referred to a pediatric nephrologist or other physician with experience in childhood HTN for evaluation and management.",
"     </li>",
"     <li>",
"      The initial evaluation includes a history, physical examination, and laboratory testing including measurement of serum BUN, creatinine, and electrolytes, and complete blood count, urinalysis, renal ultrasonography, and an echocardiogram to evaluate left ventricular mass. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Initial evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Based upon the initial history, physical examination, and laboratory evaluation, the clinician should be able to establish whether the HTN is primary or secondary. Further evaluation is performed to identify any potentially reversible cause of secondary HTN and includes other renal imaging studies (eg, renal scans or arteriogram) and measurement of plasma renin and aldosterone, and plasma and urine catecholamines. Evaluation for renovascular disease in children should be performed in a radiological center with pediatric experience in screening for these disorders. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Secondary hypertension'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/1\">",
"      National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/2\">",
"      Wyszy��ska T, Cichocka E, Wieteska-Klimczak A, et al. A single pediatric center experience with 1025 children with hypertension. Acta Paediatr 1992; 81:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/3\">",
"      Flynn J, Zhang Y, Solar-Yohay S, Shi V. Clinical and demographic characteristics of children with hypertension. Hypertension 2012; 60:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/4\">",
"      Flynn JT. Differentiation between primary and secondary hypertension in children using ambulatory blood pressure monitoring. Pediatrics 2002; 110:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/5\">",
"      Seeman T, Palyzov&aacute; D, Dusek J, Janda J. Reduced nocturnal blood pressure dip and sustained nighttime hypertension are specific markers of secondary hypertension. J Pediatr 2005; 147:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/6\">",
"      Marcus CL, Greene MG, Carroll JL. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med 1998; 157:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/7\">",
"      Enright PL, Goodwin JL, Sherrill DL, et al. Blood pressure elevation associated with sleep-related breathing disorder in a community sample of white and Hispanic children: the Tucson Children's Assessment of Sleep Apnea study. Arch Pediatr Adolesc Med 2003; 157:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/8\">",
"      Li AM, Au CT, Ho C, et al. Blood pressure is elevated in children with primary snoring. J Pediatr 2009; 155:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/9\">",
"      Horne RS, Yang JS, Walter LM, et al. Elevated blood pressure during sleep and wake in children with sleep-disordered breathing. Pediatrics 2011; 128:e85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/10\">",
"      Brady TM, Fivush B, Flynn JT, Parekh R. Ability of blood pressure to predict left ventricular hypertrophy in children with primary hypertension. J Pediatr 2008; 152:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/11\">",
"      Ramaswamy P, Patel E, Fahey M, et al. Electrocardiographic predictors of left ventricular hypertrophy in pediatric hypertension. J Pediatr 2009; 154:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/12\">",
"      Belsha CW, Wells TG, McNiece KL, et al. Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens 1998; 11:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/13\">",
"      Sorof JM, Alexandrov AV, Cardwell G, Portman RJ. Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2003; 111:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/14\">",
"      Hanevold C, Waller J, Daniels S, et al. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 2004; 113:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/15\">",
"      Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 1998; 97:1907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/16\">",
"      Schieken RM, Schwartz PF, Goble MM. Tracking of left ventricular mass in children: race and sex comparisons: the MCV Twin Study. Medical College of Virginia. Circulation 1998; 97:1901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/17\">",
"      Gidding SS. The aging of the cardiovascular system: when should children be treated like adults? J Pediatr 2002; 141:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/18\">",
"      Feig DI, Nakagawa T, Karumanchi SA, et al. Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int 2004; 66:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/19\">",
"      Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA 2007; 298:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/20\">",
"      Ahmed M, Eggleston D, Kapur G, et al. Dimercaptosuccinic acid (DMSA) renal scan in the evaluation of hypertension in children. Pediatr Nephrol 2008; 23:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/21\">",
"      Friedman K, Wallis T, Maloney KW, et al. An unusual cause of pediatric hypertension. J Pediatr 2007; 151:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/22\">",
"      Dillon MJ, Ryness JM. Plasma renin activity and aldosterone concentration in children. Br Med J 1975; 4:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2729/abstract/23\">",
"      Guzzetta PC, Potter BM, Ruley EJ, et al. Renovascular hypertension in children: current concepts in evaluation and treatment. J Pediatr Surg 1989; 24:1236.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6088 Version 19.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-222.169.60.2-DB8828736C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2729=[""].join("\n");
var outline_f2_42_2729=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Primary versus secondary hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Comorbid risk factors and diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INITIAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      History and physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Secondary versus primary hypertension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - CVD risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Evidence of target-organ damage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Laboratory evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      FURTHER EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Primary hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Secondary hypertension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Renal imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Plasma renin activity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Plasma and urine catecholamines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Renovascular imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Our approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6088\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6088|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/3/12351\" title=\"figure 1\">",
"      Nomogram for BMI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6088|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/42/13999\" title=\"picture 1A\">",
"      Cotton wool spots",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/27/39359\" title=\"picture 1B\">",
"      Grade IV HTN retinopathy I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/44/19136\" title=\"picture 1C\">",
"      Grade IV HTN retinopathy II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6088|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/45/7894\" title=\"table 1\">",
"      Normal BP boys",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/46/7910\" title=\"table 2\">",
"      Normal BP girls",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/60/28621\" title=\"table 3\">",
"      Causes HTN children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/40/31372\" title=\"table 4\">",
"      History for hypertensive child or adolescent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/61/32733\" title=\"table 5\">",
"      Physical findings in the hypertensive child",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?9/15/9463?source=related_link\" title=\"calculator 1\">",
"      Calculator: Blood pressure percentiles for boys (2 to 17 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?9/33/9751?source=related_link\" title=\"calculator 2\">",
"      Calculator: Blood pressure percentiles for girls (2 to 17 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?35/14/36070?source=related_link\" title=\"calculator 3\">",
"      Calculator: Body Mass Index (BMI) percentiles for boys (2 to 20 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?34/60/35782?source=related_link\" title=\"calculator 4\">",
"      Calculator: Body Mass Index (BMI) percentiles for girls (2 to 20 years)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/21/25943?source=related_link\">",
"      Ambulatory blood pressure monitoring in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/53/17241?source=related_link\">",
"      Approach to hypertensive emergencies and urgencies in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/52/23369?source=related_link\">",
"      Causes and clinical manifestations of primary adrenal insufficiency in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37911?source=related_link\">",
"      Clinical features of primary aldosteronism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/49/40729?source=related_link\">",
"      Clinical manifestations and diagnosis of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=related_link\">",
"      Clinical manifestations and diagnosis of coarctation of the aorta",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15609?source=related_link\">",
"      Clinical presentation, diagnosis, and staging evaluation of neuroblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=related_link\">",
"      Comorbidities and complications of obesity in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/45/17113?source=related_link\">",
"      Definition and diagnosis of hypertension in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/15/40184?source=related_link\">",
"      Diseases associated with atherosclerosis in childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/7/42105?source=related_link\">",
"      Epidemiology, risk factors, and etiology of hypertension in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/17/31001?source=related_link\">",
"      Establishing the diagnosis of renovascular hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=related_link\">",
"      Evaluation of suspected obstructive sleep apnea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24506?source=related_link\">",
"      Evaluation of the infant with ambiguous genitalia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/5/22615?source=related_link\">",
"      Familial hyperaldosteronism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4169?source=related_link\">",
"      Hypertension: Who should be treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/26/422?source=related_link\">",
"      Initial evaluation of the hypertensive adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/19/40248?source=related_link\">",
"      Lipoprotein(a) and cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=related_link\">",
"      Neurofibromatosis type 1 (von Recklinghausen's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/22/21859?source=related_link\">",
"      Ocular effects of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/37/34394?source=related_link\">",
"      Overview of the possible risk factors for cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/28/38337?source=related_link\">",
"      Patient information: High blood pressure in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/37/30290?source=related_link\">",
"      Patient information: High blood pressure in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/14/38121?source=related_link\">",
"      Pheochromocytoma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/18/43303?source=related_link\">",
"      Renal manifestations of tuberous sclerosis and renal angiomyolipoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/5/43096?source=related_link\">",
"      Risk factors and development of atherosclerosis in childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10810?source=related_link\">",
"      Systemic lupus erythematosus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27626?source=related_link\">",
"      Treatment of hypertension in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_42_2730="Mechanical ventilation in acute respiratory distress syndrome";
var content_f2_42_2730=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mechanical ventilation in acute respiratory distress syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/42/2730/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/42/2730/contributors\">",
"     Mark D Siegel, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/42/2730/contributors\">",
"     Robert C Hyzy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/42/2730/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/42/2730/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/42/2730/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/42/2730/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/42/2730/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ventilator-associated lung injury may be an important cause of poor clinical outcomes in patients with acute respiratory distress syndrome (ARDS). As a result, strategies of mechanical ventilation that reduce the incidence and severity of ventilator-associated lung injury are being sought. The mechanical ventilatory strategies known as low tidal volume ventilation, open lung ventilation, and high positive end-expiratory pressure (high PEEP) are reviewed here. In addition, recruitment maneuvers and titration of PEEP are described.",
"   </p>",
"   <p>",
"    The Berlin Definition of ARDS (published in 2012) has replaced the American-European Consensus Conference&rsquo;s definition of ARDS (published in 1994) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. However, it should be recognized that most evidence is based upon prior definitions. The current diagnostic criteria for ARDS are provided separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/16/10505?source=see_link&amp;anchor=H10171195#H10171195\">",
"     \"Acute respiratory distress syndrome: Clinical features and diagnosis\", section on 'Diagnostic criteria'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Epidemiology, etiology, pathogenesis, clinical features, diagnosis, prognosis, outcomes, and non-mechanical ventilation related aspects of management are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/16/10505?source=see_link\">",
"     \"Acute respiratory distress syndrome: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29945?source=see_link\">",
"     \"Acute respiratory distress syndrome: Epidemiology; pathophysiology; pathology; and etiology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/54/9065?source=see_link\">",
"     \"Supportive care and oxygenation in acute respiratory distress syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/52/9033?source=see_link\">",
"     \"Novel therapies for the acute respiratory distress syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/48/4871?source=see_link\">",
"     \"Acute respiratory distress syndrome: Prognosis and outcomes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LOW TIDAL VOLUME VENTILATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low tidal volume ventilation (LTVV) is also referred to as lung protective ventilation. The rationale for this approach is that smaller tidal volumes are less likely to generate alveolar overdistension, one of the principal causes of ventilator-associated lung injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16182?source=see_link&amp;anchor=H2#H2\">",
"     \"Ventilator-associated lung injury\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Benefit",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preponderance of evidence suggests that LTVV improves mortality, as well as other clinically important outcomes in patients with ARDS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The multicenter ARMA trial randomly assigned 861 mechanically ventilated patients with ARDS to receive LTVV (initial tidal volume of 6",
"      <span class=\"nowrap\">",
"       mL/kg)",
"      </span>",
"      or conventional mechanical ventilation (initial tidal volume of 12",
"      <span class=\"nowrap\">",
"       mL/kg)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/3\">",
"       3",
"      </a>",
"      ]. The LTVV group had a lower mortality rate (31 versus 40 percent) and more ventilator-free days (12 versus 10 days).",
"     </li>",
"     <li>",
"      A meta-analysis of six randomized trials (1297 patients) found that LTVV significantly improved 28 day mortality (27.4 versus 37 percent, relative risk 0.74, 95% CI 0.61-0.88) and hospital mortality (34.5 versus 43.2 percent, relative risk 0.80, 95% CI 0.69-0.92), when compared to conventional mechanical ventilation [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/5\">",
"       5",
"      </a>",
"      ]. This was supported by a more recent meta-analysis of four randomized trials (1149 patients) that also found that LTVV reduced hospital mortality (34.2 versus 41 percent, odds ratio 0.75, 95% CI 0.58-0.96), when compared to conventional mechanical ventilation [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a prospective cohort study of 485 patients undergoing mechanical ventilation for ARDS, each patient&rsquo;s ventilator settings were reviewed twice daily for adherence with lung protective ventilation, defined as both a tidal volume &le;6.5",
"      <span class=\"nowrap\">",
"       mL/kg",
"      </span>",
"      and a plateau airway pressure of &le;30 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/6\">",
"       6",
"      </a>",
"      ]. The cohort&rsquo;s two-year mortality was 64 percent; this was reduced by 7.8 percent among patients whose adherence with lung protective ventilation was 100 percent and 4 percent among patients whose adherence with lung protective ventilation was 50 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Harm",
"    </span>",
"    &nbsp;&mdash;&nbsp;LTVV is generally well tolerated. It was not associated with any clinically important adverse outcomes in the ARMA trial [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/3\">",
"     3",
"    </a>",
"    ]. With respect to physiologic adverse outcomes, LTVV caused hypercapnic respiratory acidosis in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/7\">",
"     7",
"    </a>",
"    ]. Hypercapnic respiratory acidosis was an expected and generally well tolerated consequence of LTVV. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Permissive hypercapnia'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Two major concerns were expressed after publication of the ARMA trial. First, the beneficial effects of LTVV may be the result of auto-PEEP rather than the low tidal volume. Second, LTVV may require increased sedation, increasing the risk of sedation-related adverse effects. These concerns have since been addressed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Auto-PEEP &ndash; In theory, the higher respiratory rates that are used to maintain minute ventilation during LTVV may create auto-PEEP by decreasing the time available for complete expiration [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/8\">",
"       8",
"      </a>",
"      ]. However, a subgroup analysis from the ARMA trial detected negligible quantities of auto-PEEP in both the LTVV and conventional mechanical ventilation groups [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/32/26119?source=see_link&amp;anchor=H5#H5\">",
"       \"Physiologic and pathophysiologic consequences of mechanical ventilation\", section on 'Auto-PEEP'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sedation &ndash; Work of breathing and patient-ventilator asynchrony may increase when tidal volumes are &lt;7",
"      <span class=\"nowrap\">",
"       mL/kg",
"      </span>",
"      of predicted body weight (PBW) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/10\">",
"       10",
"      </a>",
"      ]. While asynchrony may require increased sedation soon after the initiation of LTVV, the need for increased sedation does not appear to persist. In a post-hoc analysis of data from a single center involved in the ARMA trial, there were no significant differences in the percentage of days patients received sedatives, opioids, or neuromuscular blockade when the LTVV group was compared to the conventional mechanical ventilation group [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Breath stacking is a manifestation of asynchrony that can occur despite deep sedation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/12\">",
"     12",
"    </a>",
"    ]. It causes episodic delivery of higher tidal volumes, which may undermine the benefits of LTVV. Frequent breath stacking (more than three stacked",
"    <span class=\"nowrap\">",
"     breaths/min)",
"    </span>",
"    can be ameliorated by delivering slightly higher tidal volumes (7 to 8",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    PBW), as long as the plateau airway pressure remains less than 30 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O, or by administering additional sedation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/29/15833?source=see_link\">",
"     \"Sedative-analgesic medications in critically ill patients: Selection, initiation, maintenance, and withdrawal\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Application",
"    </span>",
"    &nbsp;&mdash;&nbsp;LTVV can be performed using a protocol similar to that used in the ARMA trial (",
"    <a class=\"graphic graphic_table graphicRef57072 \" href=\"UTD.htm?9/5/9309\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/3\">",
"     3",
"    </a>",
"    ]. The initial tidal volume is set to 8",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    PBW and the initial respiratory rate is set to meet the patient's minute ventilation requirements. Over the next one to three hours, the tidal volume is reduced to 7",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    PBW and then 6",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    PBW. The PBW is calculated using the following equations (",
"    <a class=\"graphic graphic_table graphicRef87507 \" href=\"UTD.htm?8/22/8544\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef87147 \" href=\"UTD.htm?8/24/8576\">",
"     table 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      For females: PBW = 45.5 + 0.91 * (height - 152.4)",
"     </li>",
"     <li>",
"      For males: PBW = 50 + 0.91 * (height - 152.4)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    where PBW is expressed in kg and height is expressed in cm.",
"   </p>",
"   <p>",
"    The respiratory rate is increased (up to a maximum of 35 breaths per minute) as the tidal volume is decreased, so that the ventilator continues to deliver the patient's entire minute ventilation.",
"   </p>",
"   <p>",
"    Subsequent tidal volume adjustments are made on the basis of the plateau airway pressure, as measured using a 0.5 second inspiratory breath hold. The plateau airway pressure is checked at least every four hours and after each change in PEEP or tidal volume [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/3\">",
"     3",
"    </a>",
"    ]. The goal plateau airway pressure is &le;30 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O. When the plateau airway pressure is &gt;30 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O, the tidal volume is decreased in 1",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    PBW increments to a minimum of 4",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    PBW. Measurement of the plateau airway pressure is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/10/32934?source=see_link&amp;anchor=H10#H10\">",
"     \"Pulmonary barotrauma during mechanical ventilation\", section on 'Prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A threshold plateau airway pressure below which safety is certain has not been determined. The goal plateau airway pressure of &le;30 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O is based on the ARMA trial. However, a goal plateau airway pressure &lt;28 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O is more appealing since this decreases alveolar overdistension and makes it unlikely that thresholds of lung strain will be exceeded [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. It seems reasonable to strive to keep the plateau airway pressure as low as possible, using LTVV even if the plateau airway pressure is already below 30 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A reasonable oxygenation goal during LTVV is an arterial oxygen tension (PaO",
"    <sub>",
"     2",
"    </sub>",
"    ) between 55 and 80 mmHg (7.3 to 10.6 kPa) or an oxyhemoglobin saturation (SpO",
"    <sub>",
"     2",
"    </sub>",
"    ) between 88 and 95 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/3\">",
"     3",
"    </a>",
"    ]. This is typically achieved by adjusting the fraction of inspired oxygen (FiO",
"    <sub>",
"     2",
"    </sub>",
"    ) and the applied PEEP. The allowable combinations of FiO",
"    <sub>",
"     2",
"    </sub>",
"    and PEEP that were used in the ARMA trial are included in the table (",
"    <a class=\"graphic graphic_table graphicRef57072 \" href=\"UTD.htm?9/5/9309\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The use of a written protocol outlining how to provide lung protective mechanical ventilation is associated with enhanced compliance with LTVV in patients with ARDS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/16\">",
"     16",
"    </a>",
"    ]. This approach should be considered in all institutions that provide care to such patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Permissive hypercapnia",
"    </span>",
"    &nbsp;&mdash;&nbsp;LTVV frequently requires permissive hypercapnic ventilation (PHV), a ventilatory strategy that accepts alveolar hypoventilation in order to maintain a low alveolar pressure and minimize the complications of alveolar overdistension (eg, ventilator-associated lung injury). Hypercapnia and respiratory acidosis are a consequence of this strategy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/31/27127?source=see_link\">",
"     \"Permissive hypercapnia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The degree of hypercapnia can be minimized by using the highest respiratory rate that does not induce auto-PEEP and shortening the ventilator tubing to decrease dead space [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/17\">",
"     17",
"    </a>",
"    ]. In addition, changing from a heat and moisture exchanger to a heated humidifier appears to decrease hypercapnia by decreasing dead space ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Animal studies suggest that PHV may attenuate ventilator-associated lung injury by effects that are independent of the LTVV from which it results [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. It is uncertain if this effect exists in humans. In a post hoc analysis of the ARMA trial, respiratory acidosis was associated with reduced 28-day mortality in the control group, but not the LTVV group [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/7\">",
"     7",
"    </a>",
"    ]. There are several reasonable interpretations of these data, including the possibility that respiratory acidosis is protective against ventilator-associated lung injury [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     OPEN LUNG VENTILATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Open lung ventilation is a strategy that combines low tidal volume ventilation (LTVV) and enough applied PEEP to maximize alveolar recruitment. The LTVV aims to mitigate alveolar overdistension, while the applied PEEP seeks to minimize cyclic atelectasis. Together, these effects are expected to decrease the risk of ventilator-associated lung injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16182?source=see_link\">",
"     \"Ventilator-associated lung injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Benefit",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some clinical trials indicate that open lung ventilation may improve mortality, other clinically important outcomes, and oxygenation. However, these trials had methodologic flaws of such importance that additional evidence is necessary before open lung ventilation is incorporated into routine clinical practice.",
"   </p>",
"   <p>",
"    One multicenter trial randomly assigned 53 patients with ARDS to receive open lung ventilation or conventional ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/22\">",
"     22",
"    </a>",
"    ]. The open lung ventilation group had a lower 28 day mortality (38 versus 71 percent) and hospital mortality (45 versus 71 percent), but only 28 day mortality was statistically significant. This trial had several important limitations: mortality in the control group was unexpectedly high, most of the survival benefit in the open lung ventilation group inexplicably occurred within the first three days after randomization, and the trial was conducted at two sites in Brazil where many of the patients had leptospirosis.",
"   </p>",
"   <p>",
"    A second multicenter trial randomly assigned 103 patients with ARDS to receive open lung ventilation or conventional mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/23\">",
"     23",
"    </a>",
"    ]. The open lung ventilation group had lower ICU mortality (32 versus 53 percent), lower hospital mortality (34 versus 56 percent), and more ventilator free days (11 versus 6 days). However, the trial had several important limitations, including that the control group was ventilated with high tidal volumes and had a mortality rate that was higher than most ARDS trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Harm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Open lung ventilation is generally well tolerated. It was not associated with any clinically important adverse outcomes in either of the trials described above [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. With respect to physiologic adverse outcomes, the open lung ventilation group had greater hypercapnia in one of the trials [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/22\">",
"     22",
"    </a>",
"    ]. This required a strategy of permissive hypercapnic ventilation, which was well tolerated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/31/27127?source=see_link\">",
"     \"Permissive hypercapnia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Application",
"    </span>",
"    &nbsp;&mdash;&nbsp;A universally accepted protocol for open lung ventilation has not been established. In general, LTVV is applied as described above and applied PEEP is set at least 2 cm above the lower inflection point of the pressure volume curve are used. Applied PEEP of 16 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O is used if the lower inflection point is uncertain. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Titrating PEEP'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    An alternative approach has been studied in which PEEP was set at a high level following a recruitment maneuver and then incrementally decreased until both the static lung compliance decreased and the oxyhemoglobin saturation decreased by two percent from the previous measurement [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/24\">",
"     24",
"    </a>",
"    ]. The PEEP was then set 2 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O above this level. There were no differences in any clinical outcome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     HIGH PEEP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The high PEEP approach is a type of open lung ventilation that does not require pressure-volume curves. This is advantageous because pressure-volume curves are difficult to construct and generally require neuromuscular blockade.",
"   </p>",
"   <p>",
"    The rationale for delivering a high level of applied PEEP to patients with ARDS is that the applied PEEP opens collapsed alveoli, which decreases alveolar overdistension because the volume of each subsequent tidal breath is shared by more open alveoli [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. If the alveoli remain open throughout the respiratory cycle, cyclic atelectasis is also reduced. Alveolar overdistension and cyclic atelectasis are the principal causes of ventilator-associated lung injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16182?source=see_link&amp;anchor=H2#H2\">",
"     \"Ventilator-associated lung injury\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Benefit",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effects of high PEEP on patients with ARDS have been studied in randomized trials [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. The trials found that high PEEP increased oxygenation and improved some clinical outcomes when compared to low PEEP. A mortality benefit was not detected, but the trials were underpowered to identify small differences or to evaluate subgroups.",
"   </p>",
"   <p>",
"    The randomized trials were subsequently pooled in a meta-analysis (2299 patients), which found that patients who were mechanically ventilated using a high PEEP strategy had lower ICU mortality than those mechanically ventilated using a low PEEP strategy (28.5 versus 32.8 percent, adjusted RR 0.87, 95% CI 0.78-0.97) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/31\">",
"     31",
"    </a>",
"    ]. There was also a trend toward lower hospital mortality. The meta-analysis confirmed that high PEEP improved oxygenation, increased ventilator-free days, and decreased the need for rescue therapy (eg, prone ventilation).",
"   </p>",
"   <p>",
"    When the meta-analysis separated the 404 patients with a",
"    <span class=\"nowrap\">",
"     PaO",
"     <sub>",
"      2",
"     </sub>",
"     /FiO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    of 201 to 300 mmHg (26.7 to 40 kPa) from the 1892 patients with a",
"    <span class=\"nowrap\">",
"     PaO",
"     <sub>",
"      2",
"     </sub>",
"     /FiO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    &le;200 mmHg (26.6 kPa), only those with a",
"    <span class=\"nowrap\">",
"     PaO",
"     <sub>",
"      2",
"     </sub>",
"     /FiO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    &le;200 mmHg who were mechanically ventilated using a high PEEP strategy had a lower ICU mortality (30.3 versus 36.6 percent, RR 0.85, 95% CI 0.76-0.95) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/31\">",
"     31",
"    </a>",
"    ]. There was no improvement and, possibly, worsening of both the ICU and hospital mortality among patients with a",
"    <span class=\"nowrap\">",
"     PaO",
"     <sub>",
"      2",
"     </sub>",
"     /FiO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    of 201 to 300 mmHg who were mechanically ventilated using a high PEEP strategy.",
"   </p>",
"   <p>",
"    ARDS is a heterogeneous disease. Some patients have a lot of recruitable lung, while others have little recruitable lung as defined by CT scan [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/32\">",
"     32",
"    </a>",
"    ]. It has been suggested that the benefits of high PEEP have been underestimated because its advantages in patients with a lot of recruitable lung were mitigated by its detrimental effects in patients with little recruitable lung [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/33\">",
"     33",
"    </a>",
"    ]. This notion was supported by a study that found that high PEEP reduced cyclic atelectasis to a greater extent than it increased alveolar strain among patients with a lot of recruitable lung [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/34\">",
"     34",
"    </a>",
"    ]. In contrast, it increased alveolar strain without reducing cyclic atelectasis among patients with little recruitable lung. Future trials comparing higher levels of PEEP to lower levels should be restricted to patients with a significant amount of recruitable lung, since this population is most likely to benefit from high PEEP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16182?source=see_link\">",
"     \"Ventilator-associated lung injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Harm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased applied PEEP has the potential to cause pulmonary barotrauma or ventilator-associated lung injury by increasing the plateau airway pressure and causing alveolar overdistension. It also has the potential to decrease blood pressure by reducing cardiac output [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/29,35\">",
"     29,35",
"    </a>",
"    ]. However, these adverse effects have not been universally reported [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Application",
"    </span>",
"    &nbsp;&mdash;&nbsp;A universally accepted method for applying high PEEP has not been established, in part because the randomized trials have used different approaches. As an example, the ALVEOLI trial used a table of allowable combinations of applied PEEP and FiO",
"    <sub>",
"     2",
"    </sub>",
"    , while another trial applied the highest PEEP possible until a plateau airway pressure of 28 to 30 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O was reached [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/29\">",
"     29",
"    </a>",
"    ]. The high PEEP strategy was combined with LTVV in both trials. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Low tidal volume ventilation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Presently, there is insufficient evidence to recommend a single approach for selecting the optimal level of PEEP when using a strategy of high PEEP. For most centers, reasonable approaches include either adopting the allowable combinations of PEEP and FiO",
"    <sub>",
"     2",
"    </sub>",
"    used in the high PEEP arm of the ALVEOLI trial (",
"    <a class=\"graphic graphic_table graphicRef62961 \" href=\"UTD.htm?6/20/6475\">",
"     table 4",
"    </a>",
"    ) or applying the highest PEEP possible until a plateau airway pressure of 28 to 30 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O is reached. Techniques incorporating esophageal pressure measurements or static pressure-volume curves to identify the optimal PEEP may be considered in centers with the appropriate expertise, but additional research is required before these approaches are more broadly recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     RECRUITMENT MANEUVERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A recruitment maneuver is the brief application of a high level of continuous positive airway pressure, such as 35 to 40 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O for 40 seconds. Most studies of recruitment maneuvers have looked at physiologic outcomes, such as oxygenation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/36-39\">",
"     36-39",
"    </a>",
"    ]. The impact of routine recruitment maneuvers on clinical outcomes is unclear, although one meta-analysis found that recruitment maneuvers did not affect mortality, length of hospital stay, or the incidence of barotrauma, despite improving the PaO",
"    <sub>",
"     2",
"    </sub>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/40\">",
"     40",
"    </a>",
"    ]. We believe that there is insufficient evidence to support the routine use of recruitment maneuvers in patients with ARDS. However, the possibility that some patients with ARDS may benefit from recruitment maneuvers cannot be excluded, since patients with ARDS are a heterogeneous population.",
"   </p>",
"   <p>",
"    The purpose of recruitment maneuvers is to open alveoli that have collapsed [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/41\">",
"     41",
"    </a>",
"    ]. There is no consensus regarding the best level of continuous positive airway pressure or the optimal frequency or duration of the maneuvers, although one study found that most of the alveolar recruitment occurred during the first ten seconds of the maneuver [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/42\">",
"     42",
"    </a>",
"    ]. This was followed by a decrease in the blood pressure, which recovered within 30 seconds after the recruitment maneuver. Significant alveolar overdistention does not appear to occur during a single recruitment maneuver (but may occur with frequent recruitment maneuvers) and the recruited alveoli tend to remain open when lower airway pressures are reinstituted [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/41,43,44\">",
"     41,43,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The arterial oxygen tension (PaO",
"    <sub>",
"     2",
"    </sub>",
"    ) generally increases after a recruitment maneuver [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/39\">",
"     39",
"    </a>",
"    ]. The magnitude of the increase is greatest when the recruitment maneuver is followed by high levels of PEEP (eg, 16 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O), compared to when it is followed by lower levels of PEEP (eg, 9 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/45\">",
"     45",
"    </a>",
"    ]. Some investigators have used a recruitment maneuver as a starting point from which to titrate PEEP to a minimally effective level [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Application'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Recruitment maneuvers may be particularly beneficial after a patient has been disconnected from the ventilator (eg, tubing changes, transport) because even a brief moment without PEEP can result in alveolar collapse [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. The most common adverse effects of recruitment maneuvers are hypotension and desaturation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/39\">",
"     39",
"    </a>",
"    ]. These effects are generally self-limited and without serious consequences.",
"   </p>",
"   <p>",
"    Sigh breaths are a type of recruitment maneuver characterized by the cyclic administration of a high level of continuous positive airway pressure for brief periods. As an example, a patient may receive three sigh breaths per minute at a level of 45 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/48\">",
"     48",
"    </a>",
"    ]. While some studies suggest that sigh breaths may be most beneficial for patients undergoing prone ventilation or patients with extrapulmonary causes of ARDS, other studies do not [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/49-51\">",
"     49-51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     OTHER CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several other important considerations regarding mechanical ventilation in ARDS. These include whether a trial of noninvasive mechanical ventilation should be performed, the preferred mode of mechanical ventilation, what to do if there is refractory hypoxemia, how to optimally titrate PEEP during low tidal volume ventilation (LTVV), and whether to use neuromuscular blockade.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Invasive versus noninvasive",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most clinicians use invasive mechanical ventilation for patients with ARDS because there is little clinical experience using noninvasive positive pressure ventilation (NPPV). However, NPPV may be considered in the occasional patient with ARDS who is hemodynamically stable, able to tolerate wearing a face mask, and able to maintain a patent airway. Additional studies are necessary before more precise recommendations can be provided about the role of NPPV, since the current evidence is so limited.",
"   </p>",
"   <p>",
"    A small (n = 40) trial randomly assigned patients with ARDS to receive either NPPV or high concentration supplemental oxygen [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/52\">",
"     52",
"    </a>",
"    ]. Patients receiving NPPV were more likely to have improvement of",
"    <span class=\"nowrap\">",
"     PaO",
"     <sub>",
"      2",
"     </sub>",
"     /FiO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    and less likely to require intubation (4.8 versus 36.8 percent). Several limitations undermine the conclusions that can be drawn from this trial. First, the study was small and, therefore, the estimated effect size should be considered imprecise and the risk of adverse events may have been underestimated. Second, selection bias may have been introduced since many participating physicians appeared to have favored NPPV. Third, caregivers were not blinded and this could have influenced decisions to intubate. Finally, patients greater than 70 years of age, with multiple organ failure, or a",
"    <span class=\"nowrap\">",
"     PaO",
"     <sub>",
"      2",
"     </sub>",
"     /FiO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    &lt;200 were excluded from participation and, therefore, the findings of this study cannot be applied to such patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Mode",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with ARDS can be supported using either a volume limited or a pressure limited mode of ventilation (",
"    <a class=\"graphic graphic_table graphicRef78436 \" href=\"UTD.htm?33/1/33819\">",
"     table 5",
"    </a>",
"    ). In most patients with ARDS, a volume limited mode will produce a stable airway pressure and a pressure limited mode will deliver stable tidal volumes, assuming that breath to breath lung mechanics and patient effort are stable. Abrupt changes in the airway pressure in a patient receiving volume limited ventilation, or in tidal volumes in a patient receiving pressure limited ventilation, should prompt an immediate search for a cause of an acute change in compliance (eg, pneumothorax or an obstructed endotracheal tube).",
"   </p>",
"   <p>",
"    In order to adhere to a strategy of LTVV, it is probably easier to use a volume limited approach. However, a pressure limited mode is an acceptable alternative, as long as the resulting tidal volumes are stable and consistent with the strategy of LTVV.",
"   </p>",
"   <p>",
"    Regardless of whether volume limited or pressure limited ventilation is chosen, fully supported modes of mechanical ventilation (eg, assist control) are generally favored over partially supported modes (eg, synchronized intermittent mandatory ventilation [SIMV]). This is particularly true early in the course of disease. Ultimately, the choice of mode depends primarily on clinician comfort and familiarity.",
"   </p>",
"   <p>",
"    Alternative modes of mechanical ventilation (eg, airway pressure release ventilation, high frequency ventilation) have also been used in patients with ARDS. While these modes may be useful in occasional patients who fail traditional approaches, the lack of outcome data preclude a recommendation for their routine use. These modes are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43784?source=see_link\">",
"     \"Modes of mechanical ventilation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/29/5591?source=see_link\">",
"     \"High-frequency ventilation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Refractory hypoxemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Refractory hypoxemia can occur even if the applied PEEP and FiO",
"    <sub>",
"     2",
"    </sub>",
"    are optimized. In this situation, increasing the I:E ratio by prolonging inspiratory time may improve oxygenation. The inspiratory time can be directly set during pressure limited ventilation. It is indirectly prolonged during volume limited ventilation by decreasing the inspiratory flow rate, changing from a square wave to a decelerating wave, or providing an end inspiratory breath hold. Increasing the I:E ratio will increase the mean airway pressure and may improve oxygenation in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/53-56\">",
"     53-56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prolonging the inspiratory time can be an effective means of improving oxygenation in some patients with ARDS because the parenchymal abnormalities are heterogeneous, with different areas of the lung requiring more time to open and participate in gas exchange. It can be considered in patients who remain severely hypoxemic despite a high FiO",
"    <sub>",
"     2",
"    </sub>",
"    .",
"   </p>",
"   <p>",
"    There are potential costs associated with prolonging the inspiratory time that should be considered. When the inspiratory time is increased, there is an obligatory decrease in the expiratory time. This can lead to air trapping, auto-PEEP, barotrauma, hemodynamic instability, and decreased oxygen delivery. In addition, a prolonged inspiratory time may require significant sedation or neuromuscular blockade, particularly if the inspiratory time surpasses the expiratory time (inverse ratio ventilation).",
"   </p>",
"   <p>",
"    In addition to inverse ratio ventilation, high applied PEEP should be administered to patients with refractory hypoxemia before implementing other rescue interventions (eg, high frequency ventilation). The rationale is that ARDS patients are a heterogeneous group, some of whom may have large areas of recruitable lung that will respond to applied PEEP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Titrating PEEP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of applied PEEP in patients with ARDS is to maximize alveolar recruitment and to prevent cycles of recruitment and decruitment. An optimal approach to setting applied PEEP has not been established [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/57\">",
"     57",
"    </a>",
"    ]. Titration according to physiologic measures is of theoretical, but unproven, benefit. This section describes some of the approaches to titrating applied PEEP that have been studied, although there are insufficient data to support the routine use of such strategies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Esophageal pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal pressure is an estimate of pleural pressure. It can be measured with an esophageal balloon catheter and then used to calculate the transpulmonary pressure:",
"   </p>",
"   <p>",
"    Transpulmonary pressure = airway pressure - pleural pressure",
"   </p>",
"   <p>",
"    The transpulmonary pressure can then be adjusted by titrating applied PEEP, since airway pressure is related to applied PEEP. Titrating applied PEEP to an end-expiratory transpulmonary pressure between 0 and 10 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O may reduce cyclic alveolar collapse, while maintaining an end-inspiratory transpulmonary pressure &le;25 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O may reduce alveolar overdistension [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The value of measuring esophageal pressure was evaluated in a trial that randomly assigned 61 patients with ARDS to one of the following mechanical ventilation strategies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/58\">",
"     58",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adjustment of the FiO",
"      <sub>",
"       2",
"      </sub>",
"      and applied PEEP to achieve specific transpulmonary pressures, as measured with an esophageal balloon during an end-expiratory occlusion maneuver",
"     </li>",
"     <li>",
"      Adjustment of the FiO",
"      <sub>",
"       2",
"      </sub>",
"      and applied PEEP according to a table of ventilator combinations, an approach similar to that used in the ARMA trial described above",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Both strategies were designed to maintain an arterial oxygen tension (PaO",
"    <sub>",
"     2",
"    </sub>",
"    ) between 55 and 120 mmHg (7.32 to 16 kPa), or an oxyhemoglobin saturation between 88 and 98 percent. The group whose applied PEEP was guided by esophageal pressure measurements was managed with significantly higher total PEEP (18 versus 12 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O) and had a significantly higher",
"    <span class=\"nowrap\">",
"     PaO",
"     <sub>",
"      2",
"     </sub>",
"     /FiO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    ratio (280 versus 191 mmHg [37.2 versus 25.4 kPa]), both assessed at 72 hours. The esophageal pressure group also had an almost statistically significant reduction in 28-day mortality (17 versus 39 percent, adjusted relative risk 0.46, 95% CI 0.19 to 1.00). There was no difference in the number of ICU-free days or ventilator-free days.",
"   </p>",
"   <p>",
"    We believe esophageal pressure-guided mechanical ventilation should not be used routinely in most centers until larger trials are performed investigating clinically important outcomes, such as mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/59\">",
"     59",
"    </a>",
"    ]. Improved oxygenation alone is insufficient to warrant a change in routine clinical practice because prior studies have NOT shown an association between survival and improved oxygenation, particularly when the latter is achieved with a potentially harmful mechanical ventilation strategy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/3\">",
"     3",
"    </a>",
"    ]. It is difficult for most centers to justify the inconvenience and cost of obtaining the necessary equipment and expertise without more certain evidence of clinical benefit. However, in centers that already have the necessary equipment and expertise, esophageal pressure-guided mechanical ventilation may be helpful in the management of patients with ARDS, especially if there are concerns that airway pressures do not accurately reflect distending pressures in the lung (eg, when there is external compression of the lung due to abdominal compartment syndrome, chest wall deformities, or large pleural effusion).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     PV curves",
"    </span>",
"    &nbsp;&mdash;&nbsp;In many patients with early ARDS, pressure-volume (PV) curves appear flat at low lung volumes (low compliance), become steeper at higher lung volumes (higher compliance), and then flatten again at even higher lung volumes (",
"    <a class=\"graphic graphic_figure graphicRef72036 \" href=\"UTD.htm?31/39/32381\">",
"     figure 1",
"    </a>",
"    ). The lower inflection point is the transition from low to higher compliance, while the upper inflection point is the transition from higher to low compliance. There are two methods of titrating applied PEEP that require a PV curve:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The first method involves using a level of applied PEEP that is slightly above the lower inflection point (",
"      <a class=\"graphic graphic_figure graphicRef72036 \" href=\"UTD.htm?31/39/32381\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/60-62\">",
"       60-62",
"      </a>",
"      ]. The trials of open lung ventilation described above are examples of this method. Specifically, they used an applied PEEP that was 2 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O greater than the lower inflection point that was chosen.",
"     </li>",
"     <li>",
"      The second method involves using a level of applied PEEP that matches the pressure at which lung compliance is maximized. This is determined from the PV curve (slope equals compliance) or by stepwise titration of applied PEEP with calculation of compliance at each step [",
"      <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/57,63\">",
"       57,63",
"      </a>",
"      ]. Compliance is calculated using the equation Crs =",
"      <span class=\"nowrap\">",
"       VT/(Ppl",
"      </span>",
"      - PEEP), where Crs is the compliance, VT is the tidal volume, and Ppl is the plateau airway pressure. Measurement of the plateau airway pressure is described separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/10/32934?source=see_link&amp;anchor=H10#H10\">",
"       \"Pulmonary barotrauma during mechanical ventilation\", section on 'Prevention'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Regardless of which method is chosen, inflation beyond the upper inflection point can result in alveolar overdistention and pulmonary barotrauma, as well as impaired cardiac filling and oxygen delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are significant limitations to using PV curves to identify the level of applied PEEP necessary for open lung ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/43,57,65-69\">",
"     43,57,65-69",
"    </a>",
"    ]. Among the limitations, the lower inflection point cannot be identified in some patients and neuromuscular blockade or apneic-level sedation is generally required to accurately construct a PV curve [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/57,65\">",
"     57,65",
"    </a>",
"    ]. A novel approach to plotting a pressure-volume curve that doesn't require neuromuscular blockade has been used in several clinical trials [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/32,70\">",
"     32,70",
"    </a>",
"    ]. Following five cycles of controlled ventilation, the inspiratory to expiratory ratio is set to 80 percent, the respiratory rate is set to five breaths per minute, and the tidal volume is set to 500 mL [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/71\">",
"     71",
"    </a>",
"    ]. Inspiratory flow is then administered for 9.6 seconds, during which a PV curve is generated on the ventilator screen. From this curve, the lower inflection point can be determined. This approach appears promising, but requires validation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Oxygenation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Applied PEEP can be titrated according to oxygenation. The lowest level of applied PEEP at which an adequate PaO",
"    <sub>",
"     2",
"    </sub>",
"    is maintained (with an FiO",
"    <sub>",
"     2",
"    </sub>",
"    less than 0.6) is used for ongoing mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25794937\">",
"    <span class=\"h3\">",
"     Lung ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effects of applied PEEP on lung aeration can be directly visualized by lung ultrasound [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/73\">",
"     73",
"    </a>",
"    ]. While this may prove useful in the future, additional experience is necessary before lung ultrasound is used to titrate PEEP in patients with ARDS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Oxygen delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Applied PEEP can be titrated to a maximum oxygen delivery (DO",
"    <sub>",
"     2",
"    </sub>",
"    ). This method involves calculating the DO",
"    <sub>",
"     2",
"    </sub>",
"    at each level of applied PEEP, then using the applied PEEP that corresponds with the best DO",
"    <sub>",
"     2",
"    </sub>",
"    for ongoing mechanical ventilation. The calculation of DO",
"    <sub>",
"     2",
"    </sub>",
"    is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31430?source=see_link\">",
"     \"Oxygen delivery and consumption\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23448052\">",
"    <span class=\"h2\">",
"     Neuromuscular blockade",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been hypothesized that neuromuscular blockade might benefit patients with ARDS by eliminating ventilator asynchrony and reducing chest wall elastance, leading to a favorable transpulmonary pressure and equitable distribution of delivered gas. The impact of early neuromuscular blockade on clinical outcomes in patients with severe ARDS is discussed in detail separately [",
"    <a class=\"abstract\" href=\"UTD.htm?2/42/2730/abstract/74\">",
"     74",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/54/9065?source=see_link&amp;anchor=H4#H4\">",
"     \"Supportive care and oxygenation in acute respiratory distress syndrome\", section on 'Paralysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/14/4322?source=see_link\">",
"       \"Patient information: Adult respiratory distress syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute respiratory distress syndrome (ARDS) is a type of respiratory failure characterized by the acute onset of bilateral alveolar infiltrates and hypoxemia. Diagnostic criteria for ARDS are provided separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/16/10505?source=see_link&amp;anchor=H10171195#H10171195\">",
"       \"Acute respiratory distress syndrome: Clinical features and diagnosis\", section on 'Diagnostic criteria'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For most patients, we suggest proceeding directly to invasive mechanical ventilation, rather than performing an initial trial of noninvasive positive pressure ventilation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Other considerations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest using a fully supported mode of mechanical ventilation, rather than a partially supported mode (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Volume limited and pressure limited modes are both acceptable; however, volume limited approaches have been more extensively studied and there is no evidence the pressure limited approaches confer additional benefit. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Other considerations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tidal volume and respiratory rate: For all patients, we recommend that the tidal volume and respiratory rate be managed using the strategy of low tidal volume ventilation (LTVV) (",
"      <a class=\"graphic graphic_table graphicRef57072 \" href=\"UTD.htm?9/5/9309\">",
"       table 1",
"      </a>",
"      )&nbsp;(",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). After setting the initial tidal volume based on predicted body weight (",
"      <a class=\"graphic graphic_table graphicRef87507 \" href=\"UTD.htm?8/22/8544\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef87147 \" href=\"UTD.htm?8/24/8576\">",
"       table 3",
"      </a>",
"      ), we suggest adjusting the tidal volume to achieve an inspiratory plateau airway pressure &le;30 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O, as described in the table (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Low tidal volume ventilation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Positive end-expiratory pressure (PEEP): For patients with ARDS who have a",
"      <span class=\"nowrap\">",
"       PaO",
"       <sub>",
"        2",
"       </sub>",
"       /FiO",
"       <sub>",
"        2",
"       </sub>",
"      </span>",
"      &le;200 mmHg (26.6 kPa), we recommend using a strategy of high PEEP (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). A preferred approach to determining the optimal level of high PEEP has not been established, although several reasonable techniques exist (",
"      <a class=\"graphic graphic_table graphicRef62961 \" href=\"UTD.htm?6/20/6475\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Application'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Positive end-expiratory pressure (PEEP): For patients with ARDS who have a",
"      <span class=\"nowrap\">",
"       PaO",
"       <sub>",
"        2",
"       </sub>",
"       /FiO",
"       <sub>",
"        2",
"       </sub>",
"      </span>",
"      of 201 to 300 mmHg (26.7 to 40 kPa), there is no evidence that a strategy of high PEEP is beneficial. Thus, the applied PEEP can be determined using the approach employed in low tidal volume ventilation (",
"      <a class=\"graphic graphic_table graphicRef57072 \" href=\"UTD.htm?9/5/9309\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Application'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The routine use of ventilatory approaches of open lung ventilation, high PEEP, and recruitment maneuvers continue to be investigated, but cannot be recommended at this time. Trials of these modalities may be worthwhile in patients with refractory hypoxemia, prior to initiating other rescue therapies (eg, high frequency ventilation). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'High PEEP'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Open lung ventilation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Recruitment maneuvers'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/1\">",
"      Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/2\">",
"      Artigas A, Bernard GR, Carlet J, et al. The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 157:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/3\">",
"      Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/4\">",
"      Putensen C, Theuerkauf N, Zinserling J, et al. Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury. Ann Intern Med 2009; 151:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/5\">",
"      Petrucci N, De Feo C. Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev 2013; 2:CD003844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/6\">",
"      Needham DM, Colantuoni E, Mendez-Tellez PA, et al. Lung protective mechanical ventilation and two year survival in patients with acute lung injury: prospective cohort study. BMJ 2012; 344:e2124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/7\">",
"      Kregenow DA, Rubenfeld GD, Hudson LD, Swenson ER. Hypercapnic acidosis and mortality in acute lung injury. Crit Care Med 2006; 34:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/8\">",
"      de Durante G, del Turco M, Rustichini L, et al. ARDSNet lower tidal volume ventilatory strategy may generate intrinsic positive end-expiratory pressure in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2002; 165:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/9\">",
"      Hough CL, Kallet RH, Ranieri VM, et al. Intrinsic positive end-expiratory pressure in Acute Respiratory Distress Syndrome (ARDS) Network subjects. Crit Care Med 2005; 33:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/10\">",
"      Kallet RH, Campbell AR, Dicker RA, et al. Effects of tidal volume on work of breathing during lung-protective ventilation in patients with acute lung injury and acute respiratory distress syndrome. Crit Care Med 2006; 34:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/11\">",
"      Kahn JM, Andersson L, Karir V, et al. Low tidal volume ventilation does not increase sedation use in patients with acute lung injury. Crit Care Med 2005; 33:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/12\">",
"      Pohlman MC, McCallister KE, Schweickert WD, et al. Excessive tidal volume from breath stacking during lung-protective ventilation for acute lung injury. Crit Care Med 2008; 36:3019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/13\">",
"      Terragni PP, Rosboch G, Tealdi A, et al. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med 2007; 175:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/14\">",
"      Chiumello D, Carlesso E, Cadringher P, et al. Lung stress and strain during mechanical ventilation for acute respiratory distress syndrome. Am J Respir Crit Care Med 2008; 178:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/15\">",
"      Hager DN, Krishnan JA, Hayden DL, et al. Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 2005; 172:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/16\">",
"      Umoh NJ, Fan E, Mendez-Tellez PA, et al. Patient and intensive care unit organizational factors associated with low tidal volume ventilation in acute lung injury. Crit Care Med 2008; 36:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/17\">",
"      Richecoeur J, Lu Q, Vieira SR, et al. Expiratory washout versus optimization of mechanical ventilation during permissive hypercapnia in patients with severe acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 160:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/18\">",
"      Prin S, Chergui K, Augarde R, et al. Ability and safety of a heated humidifier to control hypercapnic acidosis in severe ARDS. Intensive Care Med 2002; 28:1756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/19\">",
"      Broccard AF, Hotchkiss JR, Vannay C, et al. Protective effects of hypercapnic acidosis on ventilator-induced lung injury. Am J Respir Crit Care Med 2001; 164:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/20\">",
"      Sinclair SE, Kregenow DA, Lamm WJ, et al. Hypercapnic acidosis is protective in an in vivo model of ventilator-induced lung injury. Am J Respir Crit Care Med 2002; 166:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/21\">",
"      Broccard AF. Respiratory acidosis and acute respiratory distress syndrome: time to trade in a bull market? Crit Care Med 2006; 34:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/22\">",
"      Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/23\">",
"      Villar J, Kacmarek RM, P&eacute;rez-M&eacute;ndez L, Aguirre-Jaime A. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 2006; 34:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/24\">",
"      Huh JW, Jung H, Choi HS, et al. Efficacy of positive end-expiratory pressure titration after the alveolar recruitment manoeuvre in patients with acute respiratory distress syndrome. Crit Care 2009; 13:R22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/25\">",
"      Gattinoni L, Pelosi P, Crotti S, Valenza F. Effects of positive end-expiratory pressure on regional distribution of tidal volume and recruitment in adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151:1807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/26\">",
"      Malbouisson LM, Muller JC, Constantin JM, et al. Computed tomography assessment of positive end-expiratory pressure-induced alveolar recruitment in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 163:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/27\">",
"      Ranieri VM, Eissa NT, Corbeil C, et al. Effects of positive end-expiratory pressure on alveolar recruitment and gas exchange in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1991; 144:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/28\">",
"      Brower RG, Lanken PN, MacIntyre N, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/29\">",
"      Mercat A, Richard JC, Vielle B, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008; 299:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/30\">",
"      Meade MO, Cook DJ, Guyatt GH, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008; 299:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/31\">",
"      Briel M, Meade M, Mercat A, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010; 303:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/32\">",
"      Gattinoni L, Caironi P, Cressoni M, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 2006; 354:1775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/33\">",
"      Slutsky AS, Hudson LD. PEEP or no PEEP--lung recruitment may be the solution. N Engl J Med 2006; 354:1839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/34\">",
"      Caironi P, Cressoni M, Chiumello D, et al. Lung opening and closing during ventilation of acute respiratory distress syndrome. Am J Respir Crit Care Med 2010; 181:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/35\">",
"      Foug&egrave;res E, Teboul JL, Richard C, et al. Hemodynamic impact of a positive end-expiratory pressure setting in acute respiratory distress syndrome: importance of the volume status. Crit Care Med 2010; 38:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/36\">",
"      Brower RG, Morris A, MacIntyre N, et al. Effects of recruitment maneuvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high positive end-expiratory pressure. Crit Care Med 2003; 31:2592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/37\">",
"      Halter JM, Steinberg JM, Schiller HJ, et al. Positive end-expiratory pressure after a recruitment maneuver prevents both alveolar collapse and recruitment/derecruitment. Am J Respir Crit Care Med 2003; 167:1620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/38\">",
"      Lim CM, Jung H, Koh Y, et al. Effect of alveolar recruitment maneuver in early acute respiratory distress syndrome according to antiderecruitment strategy, etiological category of diffuse lung injury, and body position of the patient. Crit Care Med 2003; 31:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/39\">",
"      Fan E, Wilcox ME, Brower RG, et al. Recruitment maneuvers for acute lung injury: a systematic review. Am J Respir Crit Care Med 2008; 178:1156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/40\">",
"      Hodgson C, Keating JL, Holland AE, et al. Recruitment manoeuvres for adults with acute lung injury receiving mechanical ventilation. Cochrane Database Syst Rev 2009; :CD006667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/41\">",
"      Richard JC, Maggiore SM, Jonson B, et al. Influence of tidal volume on alveolar recruitment. Respective role of PEEP and a recruitment maneuver. Am J Respir Crit Care Med 2001; 163:1609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/42\">",
"      Arnal JM, Paquet J, Wysocki M, et al. Optimal duration of a sustained inflation recruitment maneuver in ARDS patients. Intensive Care Med 2011; 37:1588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/43\">",
"      Crotti S, Mascheroni D, Caironi P, et al. Recruitment and derecruitment during acute respiratory failure: a clinical study. Am J Respir Crit Care Med 2001; 164:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/44\">",
"      Bugedo G, Bruhn A, Hern&aacute;ndez G, et al. Lung computed tomography during a lung recruitment maneuver in patients with acute lung injury. Intensive Care Med 2003; 29:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/45\">",
"      Foti G, Cereda M, Sparacino ME, et al. Effects of periodic lung recruitment maneuvers on gas exchange and respiratory mechanics in mechanically ventilated acute respiratory distress syndrome (ARDS) patients. Intensive Care Med 2000; 26:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/46\">",
"      Jonson B, Richard JC, Straus C, et al. Pressure-volume curves and compliance in acute lung injury: evidence of recruitment above the lower inflection point. Am J Respir Crit Care Med 1999; 159:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/47\">",
"      Maggiore SM, Lellouche F, Pigeot J, et al. Prevention of endotracheal suctioning-induced alveolar derecruitment in acute lung injury. Am J Respir Crit Care Med 2003; 167:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/48\">",
"      Pelosi P, Cadringher P, Bottino N, et al. Sigh in acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 159:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/49\">",
"      Pelosi P, Bottino N, Chiumello D, et al. Sigh in supine and prone position during acute respiratory distress syndrome. Am J Respir Crit Care Med 2003; 167:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/50\">",
"      Ranieri VM, Brienza N, Santostasi S, et al. Impairment of lung and chest wall mechanics in patients with acute respiratory distress syndrome: role of abdominal distension. Am J Respir Crit Care Med 1997; 156:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/51\">",
"      Puybasset L, Gusman P, Muller JC, et al. Regional distribution of gas and tissue in acute respiratory distress syndrome. III. Consequences for the effects of positive end-expiratory pressure. CT Scan ARDS Study Group. Adult Respiratory Distress Syndrome. Intensive Care Med 2000; 26:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/52\">",
"      Zhan Q, Sun B, Liang L, et al. Early use of noninvasive positive pressure ventilation for acute lung injury: a multicenter randomized controlled trial. Crit Care Med 2012; 40:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/53\">",
"      Marcy TW, Marini JJ. Inverse ratio ventilation in ARDS. Rationale and implementation. Chest 1991; 100:494.",
"     </a>",
"    </li>",
"    <li>",
"     Marcy TW. Inverse ratio ventilation. In: Principles and Practice of Mechanical Ventilation, Tobin MJ (Ed), McGraw-Hill Inc, New York 1994. p.319.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/55\">",
"      Armstrong BW Jr, MacIntyre NR. Pressure-controlled, inverse ratio ventilation that avoids air trapping in the adult respiratory distress syndrome. Crit Care Med 1995; 23:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/56\">",
"      Mercat A, Titiriga M, Anguel N, et al. Inverse ratio ventilation (I/E = 2/1) in acute respiratory distress syndrome: a six-hour controlled study. Am J Respir Crit Care Med 1997; 155:1637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/57\">",
"      Ward NS, Lin DY, Nelson DL, et al. Successful determination of lower inflection point and maximal compliance in a population of patients with acute respiratory distress syndrome. Crit Care Med 2002; 30:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/58\">",
"      Talmor D, Sarge T, Malhotra A, et al. Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med 2008; 359:2095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/59\">",
"      Bernard GR. PEEP guided by esophageal pressure--any added value? N Engl J Med 2008; 359:2166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/60\">",
"      Muscedere JG, Mullen JB, Gan K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 1994; 149:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/61\">",
"      Mancebo J. PEEP, ARDS, and alveolar recruitment. Intensive Care Med 1992; 18:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/62\">",
"      Dreyfuss D, Saumon G. Should the lung be rested or recruited? The Charybdis and Scylla of ventilator management. Am J Respir Crit Care Med 1994; 149:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/63\">",
"      Suter PM, Fairley B, Isenberg MD. Optimum end-expiratory airway pressure in patients with acute pulmonary failure. N Engl J Med 1975; 292:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/64\">",
"      Dambrosio M, Roupie E, Mollet JJ, et al. Effects of positive end-expiratory pressure and different tidal volumes on alveolar recruitment and hyperinflation. Anesthesiology 1997; 87:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/65\">",
"      Decailliot F, Demoule A, Maggiore SM, et al. Pressure-volume curves with and without muscle paralysis in acute respiratory distress syndrome. Intensive Care Med 2006; 32:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/66\">",
"      Gattinoni L, D'Andrea L, Pelosi P, et al. Regional effects and mechanism of positive end-expiratory pressure in early adult respiratory distress syndrome. JAMA 1993; 269:2122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/67\">",
"      Maggiore SM, Jonson B, Richard JC, et al. Alveolar derecruitment at decremental positive end-expiratory pressure levels in acute lung injury: comparison with the lower inflection point, oxygenation, and compliance. Am J Respir Crit Care Med 2001; 164:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/68\">",
"      Mergoni M, Martelli A, Volpi A, et al. Impact of positive end-expiratory pressure on chest wall and lung pressure-volume curve in acute respiratory failure. Am J Respir Crit Care Med 1997; 156:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/69\">",
"      O'Keefe GE, Gentilello LM, Erford S, Maier RV. Imprecision in lower \"inflection point\" estimation from static pressure-volume curves in patients at risk for acute respiratory distress syndrome. J Trauma 1998; 44:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/70\">",
"      Grasso S, Stripoli T, De Michele M, et al. ARDSnet ventilatory protocol and alveolar hyperinflation: role of positive end-expiratory pressure. Am J Respir Crit Care Med 2007; 176:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/71\">",
"      Lu Q, Vieira SR, Richecoeur J, et al. A simple automated method for measuring pressure-volume curves during mechanical ventilation. Am J Respir Crit Care Med 1999; 159:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/72\">",
"      Albert RK. Least PEEP: primum non nocere. Chest 1985; 87:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/73\">",
"      Bouhemad B, Brisson H, Le-Guen M, et al. Bedside ultrasound assessment of positive end-expiratory pressure-induced lung recruitment. Am J Respir Crit Care Med 2011; 183:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/42/2730/abstract/74\">",
"      Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363:1107.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1653 Version 25.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-91.202.164.29-B6FAD70B64-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2730=[""].join("\n");
var outline_f2_42_2730=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LOW TIDAL VOLUME VENTILATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Benefit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Harm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Application",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Permissive hypercapnia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      OPEN LUNG VENTILATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Benefit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Harm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Application",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      HIGH PEEP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Benefit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Harm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Application",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      RECRUITMENT MANEUVERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      OTHER CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Invasive versus noninvasive",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Mode",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Refractory hypoxemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Titrating PEEP",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Esophageal pressure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - PV curves",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Oxygenation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25794937\">",
"      - Lung ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Oxygen delivery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23448052\">",
"      Neuromuscular blockade",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/1653\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1653|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/39/32381\" title=\"figure 1\">",
"      Tidal volume airway pressure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1653|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/5/9309\" title=\"table 1\">",
"      Low tidal volume vent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/22/8544\" title=\"table 2\">",
"      Predicted body weight and tidal volume for men",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/24/8576\" title=\"table 3\">",
"      Predicted body weight and tidal volume for women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/20/6475\" title=\"table 4\">",
"      High PEEP vent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/1/33819\" title=\"table 5\">",
"      Comparison of ventilation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/16/10505?source=related_link\">",
"      Acute respiratory distress syndrome: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29945?source=related_link\">",
"      Acute respiratory distress syndrome: Epidemiology; pathophysiology; pathology; and etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/48/4871?source=related_link\">",
"      Acute respiratory distress syndrome: Prognosis and outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/29/5591?source=related_link\">",
"      High-frequency ventilation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43784?source=related_link\">",
"      Modes of mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/52/9033?source=related_link\">",
"      Novel therapies for the acute respiratory distress syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31430?source=related_link\">",
"      Oxygen delivery and consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/14/4322?source=related_link\">",
"      Patient information: Adult respiratory distress syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/31/27127?source=related_link\">",
"      Permissive hypercapnia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/32/26119?source=related_link\">",
"      Physiologic and pathophysiologic consequences of mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/10/32934?source=related_link\">",
"      Pulmonary barotrauma during mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/29/15833?source=related_link\">",
"      Sedative-analgesic medications in critically ill patients: Selection, initiation, maintenance, and withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/54/9065?source=related_link\">",
"      Supportive care and oxygenation in acute respiratory distress syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16182?source=related_link\">",
"      Ventilator-associated lung injury",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_42_2731="Positive vs neg likelihood";
var content_f2_42_2731=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F69816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F69816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Samples of positive and negative likelihood ratios",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Poor-fair",
"       </td>",
"       <td class=\"subtitle1\">",
"        Good",
"       </td>",
"       <td class=\"subtitle1\">",
"        Excellent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Positive likelihood ratio",
"       </td>",
"       <td>",
"        2.1 - 5.0",
"       </td>",
"       <td>",
"        5.1 - 10.0",
"       </td>",
"       <td>",
"        &gt;10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Negative likelihood ratio",
"       </td>",
"       <td>",
"        0.5 - 0.2",
"       </td>",
"       <td>",
"        0.19 - 0.1",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2731=[""].join("\n");
var outline_f2_42_2731=null;
var title_f2_42_2732="High fiber diet 3 PI";
var content_f2_42_2732=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F76458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F76458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Sample menu for a high-fiber diet for children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Sample menu (for a 7- to 10-year old)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Breakfast",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 cup instant oatmeal",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 slice whole-grain toast",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 teaspoon margarine or butter",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 medium banana",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       8 ounces skim milk",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Lunch",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Turkey sandwich on whole-grain bread",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 teaspoon mustard",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 ounce whole-grain chips",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 medium apple",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       8 baby carrots",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Bottled water",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Snack 1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       4 fig bar cookies",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       8 ounces skim milk",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Dinner",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       3 ounces pork tenderloin",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1/2 cup mashed sweet potatoes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1/2 cup green beans",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1 small whole-grain roll",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       2 teaspoons margarine or butter",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       8 ounces skim milk",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Snack 2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1/2 cup vanilla bean ice cream",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2732=[""].join("\n");
var outline_f2_42_2732=null;
var title_f2_42_2733="Antiepileptic drugs in children part I";
var content_f2_42_2733=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drug therapy for seizures in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Dose",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Blood level",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Laboratory",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Starting",
"       </td>",
"       <td class=\"subtitle2\">",
"        Maintenance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbamazepine",
"       </td>",
"       <td>",
"        10-20 mg/kg/day",
"       </td>",
"       <td>",
"        10-35 mg/kg/day",
"       </td>",
"       <td>",
"        4-12 mcg/mL",
"       </td>",
"       <td>",
"        CBC after initial 4-6 weeks, then prn. If initial WBC low (particularly AMC) repeat as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Clobazam&nbsp;",
"       </td>",
"       <td>",
"        Children &lt;2 y.o. 0.5-1 mg/kg/day&nbsp;",
"       </td>",
"       <td rowspan=\"2\">",
"        0.5-1 mg/kg/day (max 40 mg/day)&nbsp;",
"       </td>",
"       <td rowspan=\"2\">",
"        Not established&nbsp;",
"       </td>",
"       <td rowspan=\"2\">",
"        Routine lab tests not recommended&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Children 2-16 y.o. 5 mg/day&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clonazepam",
"       </td>",
"       <td>",
"        0.01-0.03 mg/kg/day",
"       </td>",
"       <td>",
"        0.1-0.2 mg/kg/day",
"       </td>",
"       <td>",
"        Not used",
"       </td>",
"       <td>",
"        If clinically indicated (bruising, unexplained fevers, etc)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clorazepate",
"       </td>",
"       <td>",
"        0.3 mg/kg",
"       </td>",
"       <td>",
"        0.5-3.0 mg/kg",
"       </td>",
"       <td>",
"        Not used",
"       </td>",
"       <td>",
"        Not required",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ethosuximide",
"       </td>",
"       <td>",
"        15&nbsp;mg/kg/day",
"       </td>",
"       <td>",
"        15-40 mg/kg/day",
"       </td>",
"       <td>",
"        40-100 mcg/mL (any increase to 150)",
"       </td>",
"       <td>",
"        CBC/plts after first 1-2 months, prn thereafter",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Felbamate",
"       </td>",
"       <td>",
"        15 mg/kg/day",
"       </td>",
"       <td>",
"        15-45 mg/kg/day",
"       </td>",
"       <td>",
"        50-100 mcg/mL",
"       </td>",
"       <td>",
"        CBC/plts every 2-4 weeks, hepatic function tests every month",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gabapentin",
"       </td>",
"       <td>",
"        10-15 mg/kg/day",
"       </td>",
"       <td>",
"        40-50 mg/kg/day",
"       </td>",
"       <td>",
"        Not established (probably 7-12 mcg/mL)",
"       </td>",
"       <td>",
"        CBC/plts every 3 months for first 6 months, chemical panel prn (routine monitoring may not be necessary)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Lamotrigine+&nbsp;",
"       </td>",
"       <td>",
"        Monotherapy 0.3 mg/kg/day&nbsp;",
"       </td>",
"       <td>",
"        &nbsp;4.5-7.5 mg/kg/day",
"       </td>",
"       <td rowspan=\"3\">",
"        4-15 mcg/mL",
"       </td>",
"       <td rowspan=\"3\">",
"        CBC/plts every 3 months for first 6 months, chemical panel prn (routine monitoring may not be necessary)&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Add to VPA 0.15 mg/kg/day&nbsp;",
"       </td>",
"       <td>",
"        &nbsp;1-5 mg/kg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Add to inducer (PB, CBZ, PHT) 0.6 mg/kg/day&nbsp;",
"       </td>",
"       <td>",
"        &nbsp;5-15 mg/kg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Levetiracetam&nbsp;",
"       </td>",
"       <td>",
"        20 mg/kg/day&nbsp;",
"       </td>",
"       <td>",
"        40-60 mg/kg/day&nbsp;",
"       </td>",
"       <td>",
"        Not established&nbsp;",
"       </td>",
"       <td>",
"        Routine lab tests not recommended&nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     +: dosing for children 2-12 years of age; AMC: absolute monocyte count; CBC: complete blood count; CBZ: carbamezepine; max: maximum; PB: phenobarbital; PHT: phenytoin; plts: platelets; VPA: valproate; y.o.: years old",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2733=[""].join("\n");
var outline_f2_42_2733=null;
var title_f2_42_2734="Esophageal vs reflux parameters";
var content_f2_42_2734=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F68486&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F68486&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Reflux parameters in asthma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 240px; height: 530px; background-image: url(data:image/gif;base64,R0lGODlh8AASAtUAAP///wAzmf8AAICAgEBAQAAAAH8AAAAZTMDAwHBwcBAQENDQ0KCgoDAwMODg4CAgIFBQUPDw8P+AgLCwsEBms8DN5v/AwGBgYJCQkICZzP9AQCBNpuDm8/8QEP+goNDZ7P+wsKCz2TBZrP9QUHCNxv9wcP/g4P/Q0P+QkPDz+WCAv7DA3xBAn5Cm01Bzuf/w8P8wMP8gID8AAAAMJv9gYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAADwABICAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4h+CAiJjY5QAwOPk5RHkZWYlZeZnI2bnaCFn6GkgKOlqHunqax2q62wca+xtGyztbhSEQyRDkMTAxi+SLe5xk0DBcoKvgkFDQrMxJLH1VEIvhAFAxEFCgAYBQnT1uVRFwUMCAUEAOvt7pHyBNTm9koLz+7s+/AI8pHo3Rt4hIGCBhEA5GsAYEIBCOQISgTnLcEABgAeFJigDaOlehPvEVCmrN2CBhWTFAvJ8mPLl8hAwpxZZCXBfwBz6tzJs2dP/0aEbA4cIMOA0aNIkypdyrSpURkyTUVtOcCAgKtYs2rdyrWr16sGpvoReq/q17No0woIK0psSLNq48pd65YPWXtw5+r9yjZoXYl59wrW2nfQXXOBBysuLOhwucSKBTMO5Nga5Mh6J0ulKeQyZrma/1Su5vmz2tBj/xIsbRot6j6jj7FuzVd1ntjGZtPu+tqu7bJWd8/treo33uDC4xLXgzuX7uRZl982jhg5dNfU6zTH9fw63bacAXS/Lh3P9lrjoZe/c55W+uTrXWW3bN271/ja55Oub58rfjrtxfKecP/NESAsA+5WoBwHtpIgbQvKop9s/PVH2IQShvdgaxHC0f8gKxua1uEbH6YS4mcjbrEAUAotskhCLnF2ImYpYuGAQQUMMRJJLNaEoXMVWohVjVcko4yOBWDwYkQ0zRgZkVgcKcRIDRDgEU4ACSRjkEJ+F4eUAFiUgAIbxZOTlk1yKSSUV4A5RDJilYiKk4v9qIUD6xSATUYJjKknkzPRORibVBipjCTaFPCARzGm2SVvdrohZymCShZpG5OSUulehBaxI0kQwJhFpqFsmtmlSRBQJQEHbbMFqaCYOhyqSDwAVAIXXADPqLQ6qKaFnRJRwAUARAABPbtiAWsnsoLWqxHokDTABRBpsSwnzSr3bBERDEAAARgoNAyvGv7aX7BmXJv/SbanbdsZSSQlS24VWPpk77349pgGu2mha2i8XTQ3wAwHFGzwwQgnrPDCDBc8g7tO8IvdGN+CIfABAWSs8cYcd+zxxyBnfADEyJhrH7o6yvvqjwNgHPLLMMc8MqYme4cuTg88EAmj1rLscsxAB63xzLbUTB7E/5YUsM9CNw000WtIfNbNOvE8b6E/O621x1CrIXVt4FXR8tZkd9z1vkarRzIZF5fttshrL/H1fXGL0fbbZZ+NxtyQho013nnXrVLa8MW94iILLG3F2IBvrfcZfPu3dqJKc3F3404/ni7hBK79jDxWK8s05pkLTgznCq5NwDgWj0660JqXEflWKLuj/8C3qysudtavy2y6JahDuDaZAFvueu++0/yo5GIowPoXlyMPc+xsB8/h2gkQ4GLixi/Ou/QgUz/G7BeK8Sk/3e8OfvJFL0/72ryAjk+PwAij0vHrfyy+3daL+HsSNyLTEJwBDWk0agqMy1/4/leT/qFobRHAgPwsQRIhdOMb4Xiej7ynwJDtLwzki87aNFI8JEjpHf0wU5bw18GNfdBiDqSR5yCwPSWckB8orFdAWNhCuCnPfSIUA66cIKWFNOQhgJJCAnvoQgYSIYRDgh+8VCYEPCljTxrhSDqSGIUlMtGH7QNiFMXgDdxp8InwksRJUsJFSHyPiS+EXgyfNEKSRf/viwGIoxegCBbs6WxnuvsbHofmxDfNsU7mm2IgEfjGHuoxYIcc1NoOh7hFKrGRLXyk5SJpKb8xcpCE/KEYvWQYHjqykJ3hJKdQebVPgjKPrOQjKRtjykzGUpWn8uQlXwlLUYqxduOrZQc1+SpczkqXXcTkMG85yj4i0428JKa1jOmsZz7Bi1+U5qioqS1rRkyZCtSmsrjZLm8iA5z5E2eRyNkvVoqOg69U5+LYOTG/wBOU8hQbPafmziIJM5zMbCYw7fbPdAZ0lAMFYUHXl89C7RNs9lRfPA/6y34ubqHgaygCH0o3czIBm3CkKBAT2rp7DlKjSuRo3yIqSHyK1H3/JIUeRqWH0i6qlHksdaVLfTlSix6BkggQ1QYlutMwItSnRjifvt40U+TVFBI3fd8dRqKkoLbxmuhk6EuXF1MoUMlKQ9AhmnR60q0+qqtPEBOZJiAEsTa1d0+9ZlTLdxtXHXCXE+UpTJFahAf0iUxL7cxbXxfXiM01iHZI1KLuZ1I8FrZkzZwlZQZLusd+9LBjzCleixo1zDpTs8mMplm7hNb0tbSseuUqX5VIWcxZVm6elexmiIpao1bUo3LLakZHu6bVdrG1jXutEmRZ2pU1Npu8BZZvIQFcwAl3cJEtbs+OG9LUnnW512wu3p57uuhiN2LafRt3gedd3A5XtzRN/+65vhsT6p7SuqRl70fD67bxGoG48pUbfQMH396aVyXodap6T5bf4e6XbPZtYHlBC8282ran/yVGgOE6YJsVmLG0dWyFjxZhS0yYsBtWW4fv++HKhrhwI65JiV174s7dYRcXEepQT6vh/ir3DiihEoZpjFwbr9cODoGINth619A6uLMLBpCr4NTWM9EDXzwhAMEaRuUqW3kGT4aylqFMgKI45ctgDrMMsiyPwO5tyXYVK5m3zOY2u/nN33qznOe8ZTOfIYNhStJVNXVhQThAUQjQyLhm7KA+C4IBGlnsnktlaE00eo+PnoS6zBPpRyyCFpcOj6Y3zelOe/rToA61qP9HTepSm/rUqE61qlcdCwaEbguZZjUgjqVQWQcC0TU0ra37cD4qXnTXf4gfIHUN7EzgiXtFLvZUFfmECOR4x8rOQ/a+JQ4oOAN9yY42HhpgnHUkY1du1XYfIvAAXxuB3AlAYZNXKO48nI9YTchTCQndbjpMmwAXkHESIrCIcDQA2fSudyLUnW2Bu8FYbCS2weEwElXZ1bgLn0OZwmTuQlV61QqQhLGqBfGIx+HayiByxz0OBwwQAAIiHznJMTHplRcEd2a0ZBTuDfOa2/zmOM/5zc/o6aRhe7pVIAAvM1bx8OAJAQ1oQCUV7tWhB6Dom66YTK0g9KFDnSZHT/rSVR7/harz8uqBglfluN50q4+aATbnuT+p7nSwL7w5Xn+l2w0O97a7HNpSiDso5y7wupud1H2qddDtTmpdCZ4Keh8k31+CgYwPuwkT0BXK8d51wo+6109QFUoKMOgn/ijxeFx8S4AK8CUMYySlZyrb/05qYDhgAKnHx0jULtjVf73U10YABODthNdDg3vhHjzrRa2ACyjdW08YhjOoEXzEW17UetKe4YlYpSsumgmg/6LoWaKqB2gjXE4w+cnt7Pfbk3oBxEOIzMtu/lIjIPbvFH77RR2B7E1+/Zl/fqjPl/JW5l3/oOYqzrZ9lMd+cldq9zcAHAd0zjd8oXYB5UYAOZM7/ww4BdnHRAQ4EeczdvHXgPN3d55newcIgvf1eQBIguU3giQYgvKngqLmasbCe2SXfw4Iag+AAdECfjPoBBfYQxkoEXpSJdmDfzx4gp6WcduAfExHgx8IarnXADLof5VXg58WQRPQLfAnNiZIhZ/merBHhE3Qgy30gwSRe7vXbPHTeSzogS4YasV3fG5nKAZUgiK4d6UWfQgwffGWDQ8XcAZoh6TWfd8nBejwauKxhU34aeinDOoHBUZ0fUsghh1EhhLxflJgEI1YcGFohJu2E4Z4BOHgPBexbvOAiG3oaWLHgZHIbM1ngZyoaYtwg4swVlL4h4p3h0SmhDu4iVzYaf8PkHFjsoC1yISnqIjEowBZaHF1eIumFmtLWIS92Gkmd3/PyIuJ6GkgN3G7iH2vuGkCSGvVyI3R6I1ENoThGIndqGna4HA6WIH/N46ahnDOA2nLGHptQHM6l4/6qI+fyAULoIYd6IrwGAYEEFlXoToX4BAFkIwIZIqAuAYFaZCeMwESCIVgKI7XWAYRGVmegwDFp4vuOIUZSQYb2Uxr0wAagYOUuIYCOZIUY5ACsDYe2QAOoADtOIzQ6JLmA5MXd4j1qH1tUJKjhDQ3AhD92JA/iYFByZNgEH3Mto3oOJBgIJRiBDFBRXoXGZU6SZBMKQb1A5BLsCIGlpQ+uJQSKUT/JIGMyYcjY9mCD6kGVAlEM4QAE6AAwjhcFVSAxPiWaRCX7nOSQAGSTeAmrfiOWzmVXQkG2RMQ9HCUwpIjYXUmDsmMEJmYX7CBP7cEbkKHbkmZcGmZXgBUW6cEVqQnYJmCfIkGfrk8EIMnRLAADIlG0gKJSiCJCrSSFgiar5IjFSN1UFmb6ciVZwk9vNkOvhmStmiPbLCaj4I0Qah0VZKVwCmVl6mb1pKKuFl7namclTmcXoB2NUd7WkiWY2iWHJliRGCb+ZOdXWedqUGek2ieJomeOhKciOmdtASftymfQ0mfU2Kf1Ymfk6Wf68mfVemfAKCe68OeXuWesDGZ3PmZ/wI6W2yYmmfAnF3Sk6jpmX3poL5BoAtqoHKJoAoKPgyaeR5aHCBqoiL6lyQKoF6AoUKioRAKlMuZosxRo0p5oxMqGjpaljx6ngy2lxyqmjg6HSsqPSfKg0dKaUmKPEsahk3KHmvGZg9gZViapQrzR3T2Zg8QZmAapktRpXZWBzrUpWiaploWZ2rapnRWpvXWciuYLj05p7Rppz6Kp44gp3oaBs7Yp4AaqII6qIRaqIZ6qIiaqIq6qI7wp4xqBQtwonxKguDpcBT4m4+qEtgpnZmKBB6pAAwQDpZ4jp0KQKyCDlNXqlXQeJDJqaqKBK4ZliwCYwMAlj75qmAQQK0qh/+nWaenlgAMIQQNQHuGElZ8GCe+amp/ljj5YKsAsJkAUIikuEO4KgVnSC2a2apC8IgqRK3VCgUO8Wf9ZwRugon6pnrfCgU58wCkmSd7EooWYYiTOqfhcJM1kUYJ+pR+mK77xg2pyq8kkqykVqkxR6rp6nPsOa93l3VKN6qYakKpGLESO7EUO7FRagzHabAmBKMtwbCjiZODybEsgbCuegQFILIhQbDfIp7KWAUnS5109yMve5g0UX8nN64BKQUzW4yexn8lS64oyxICGJ0aa7JBGxIJeJdr57JHOxEQ+C0TyLK/ZQU7a6E9u6nI+QRVW6QoKLNNq2zNsbURWmxi+Qv/wWCrYfu1nKarA/QM0dCrVKu2BMFvdEsMeXlBFME6hRkFYmujZ3dFw2pDkJlD6LO3UNC3OzpqD4CS/1BxN9QOBLevRCS394CH5gix26oPQXanGwuzMPEAxjcA83gEpYlFG9ERnGu0nvsSCukNp4mvazS6msgEiAuk53e29Mi0q/sSlBSbU6u7NDsTlJOZOcu3lGsPn/N4WTu5u8t9UvtrwMuzneaRBfuwqhu8MEE8qli8h3u85iC7uUsFtVuegKc9H8u9Wuu95YB5RQu0zZuyRvmzRTC+8amnafu+q1GUE2S97ou9QosA7Mu/86u+x3CVLuKwyxuy+DsU2vqvU0C///spaskQTHG7wGXBDjD3vEQADLWql8zrv2+BtU2ADtDwJ7OrmQScG3pywL4rBMrQLX3Ikjqbws7RwFCADovbiIabvhZsD/+wqs/gDcAnmRUMwqaWD+0QDr52v0Zcan+mAJE3LKnbv9JbbIjmDfk2xQPcw/egDkIwATgLveJLwxhLDZebwLRLxrUgb6Aiv8KixrQQqQoQgRDQwtlVxFW8aV5cUtFrtZ22AMeysm48BBBcoKRGQtu7tGPMxcirtGiMwoxsDhCgwS27yE3stLcjyO27xZcsEQH8yDYEx6XGxHkcj9kDyGE8nn3MtZ6WKHnoyKpsyaUcHkmiPYKJvh88y/+csRHac3KD7MKiTAsXEA0a4ZhDQKttKct+zGnySMkKQSYSmMwPHMyxAAwA8HotrBGxScrLvGk6MyWw/JqKohELuMO53M2aZsK3fATrAJ1bNK3e4rWRXA6gGwHOFoVIgMTiEcMybLzzbBnwAqdDkEUoQX7y3MkSgXbUyASx24/czMqd5mqHN83/XA3g6MAzXNHHgGvnq8gUjdAD8ckgm8YabQzCNoqb/MYlbQx0a1UpTcjUDAsMALjODF54jM7hsbi2ss5i/NG6TBOWm7AH/dMzAbrcBr4jDckgfQ+tO4egnASFHKKltgC4+8vPGtOs8HoYcK5JHcorTQs1uQxc7dH/Gb3U5ZBBzmCvXQ3VWD0n8ECLT925Zm0ZmTzHlxrX10vUVCHCeE3FOD0TR8fCjrgnHqzAc+1pi1gXDz224rZ5IGHOhq3XqCa6y0cEkE3Sh71p+QAM/NzP3fvVMJE0brHYfituR4cOF4C2Q/3XssZkhY3Zkt1upJ24djrbtlvbqw3RLmfb5IunvF2/vp3bjN21N63bK/fbERzcxT3cZoCP+/jc0P0txuykq8zcGjml8rHcpd2hPfqe1b3dRtrdD6rdtM3dQlpK5H3b5j2fQ3rOxr2T4v2h313e4X3e+Tnf6l3f7E0HDiBBWy3NZR3bWiCjFrJcnxKsWqzSmY2i8c0G/1dIbiZ8wl694Eza4G4gaJHJbvjd2xJq33SAZxleiunN4evdn3bgDPgsuZHN2jGK3WagDX9k0CMO3B2+3xKHrwkO06CdKi4OIMIN3hfa4wby4/Qd5BaOpBtO4yV+oO294u8tnB5OoT7N4l1A4P1BozOe3DVu4uid5Fq+5CPa5LBN5Vxg5faB5V5uyN0Z5Xma5lK95jY+oG7OokEa51Ie4GS+BWbuHWiuzE9+n2zu3X5u3SQp5AxC5Plt5IE+3nOupC3Kmgga1XQO51x+34MO5Gaw59ehoVW6ZQWgpaCupVzqpvjypWJ66mFKpopA6qze6ozp6rB+LwItbgoLsOhq6/+YIrB9Wuu4zuu27qi4HuzCPuwS8QEVwAFNEAIU8AGZYAIoIAEe8AJfUAIaYA0pkDEikAQBQAFCkAEBUAGY4AFZUe1OoAECUO7nXg0hoDHIDgAfoAIU4AIhsO4bkAEc4O0tAO8rAAD3vgLw/gErQAEkIATKHu/7rgcmIAAdYAEAcAISAAAvQO00cAIAYAISAALU/vAWEAMCIAEWYAEScAIewPAgMAIagAJCYO5CUPIaQAMMHwsiwAItEAADzwEBIAIZoAIuQAIBwALL7u0+nzEcUAEZQwE9vwEbEAAhAAA7nwFJ3+54gAICUAJFAAMdIAFWbwIWcBUa0AEC4AEe4PX/GuABEqDwHQ8CAjACJTD1AKDy4j4CEgD3sWDzKmDzG+DuAbABJNACKQAA297t3w4APF8BRJ8BAGD0AFD4/J4BFJD04J4HZf/wQ3ACbI/2KLD1D4/2D6/yAFD2ICAEIyAA0m71bX/uUg8D0E4LPL8BRh8A+x7wLHDzfs/tAODt4G77io/4hc8BLCACIaACgZ8H4k7uFY/5AID5xm/8nF/2L8/5Kr/85s72sMAC9Z7zAeACFaACK1ABLMACfr8Bx277tf/tuR8AiR8AGUD02G/0j58HHK8BcV/tHRADFhD6J5D8HV/6IODwAgAEFgAAJZCABCOARkAsWTzJ4ZRatV6x/1ntltsdrgKkYSoQ+IjKog8gU/60K+xApRLIACgBQP2uCrDQ4rwGCbtMRgQEYlAATmAUPQAsjCQpQToEUCQEhIZKMEdelppAYhJDC1NVV1lbXV9hY2VnaWttb3FzdXd5e31/gYOFh4mLjY9zK9bGQjJCUqg4lJGDLSxEp04sTKi7Vd8CKKbQ8kSmUsi9e6M4szEl1LudWyhUoKXp6Jbzwr8CXAC4CLBiCIky4uIVMnGkhAZ4jaxF5AbABKZ2Qx5RSngszYYAKuSUOTilDsI2d07usdNv46BJAjRgisQkUaKHGnBelNChhMaWxPqRQZil5JCUJ1NsIFH0Z5dJ8JA8vKOCooMJJkJOCACxSWrTYCz7haAwdqyYIUxbhAFgsEUdkSy9ZnlaCV5DnDhn1kxkYZPernF7gRVXIUPhwiGGfEgrokIKDgE2VPDIIQWdxcsAX5k714MEz56xWnuE4oUJazQE0JiYOTBCuFf4lYkTwuMGxCRfs6ay2WeWq1S46hY+nHhx48eRJ1e+nHlz58+hR5c+nXp169exZ9e+nXt379/Bbw8CADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lower esophageal sphincter pressure (top panel) and reflux parameters, number of episodes per hour and percent time that esophageal ph was below 4.0 (middle and lower panels) in patients with asthma and control subjects. Compared to controls, asthmatics had significantly decreased lower esophageal sphincter pressure, more frequent reflux episodes, and higher esophageal acid contact times.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Sontag, SJ, O'Connell, S, Khandelwal, S, Gastroenterology 1990; 99:613.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2734=[""].join("\n");
var outline_f2_42_2734=null;
var title_f2_42_2735="AIM 75_10";
var content_f2_42_2735=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F81370&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F81370&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Doxorubicin (Adriamycin), ifosfamide, and mesna (AIM 75/10) for advanced soft tissue sarcoma",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td colspan=\"4\">",
"        Cycle duration: 21 days.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Doxorubicin",
"        </strong>",
"       </td>",
"       <td>",
"        25 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per day IV",
"       </td>",
"       <td>",
"        Dilute with 1000 mL normal saline (NS) and administer as a continuous IV infusion over 24 hours daily.",
"       </td>",
"       <td>",
"        Days 1 through 3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Ifosfamide",
"        </strong>",
"       </td>",
"       <td>",
"        2000 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per day IV",
"       </td>",
"       <td>",
"        Dilute with NS to a final concentration of 0.6 to 20 mg/mL and administer over two hours daily. First dose on day 1 can be mixed with first bolus dose of mesna in the same bag.",
"       </td>",
"       <td>",
"        Days 1 through 5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Mesna",
"        </strong>",
"        *",
"       </td>",
"       <td>",
"        1600 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on day 1, followed by 1200 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV daily",
"       </td>",
"       <td>",
"        Administer 400 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        in NS over two hours with initial ifosfamide dose on day 1. Total concentration of mesna should not exceed 20 mg/mL. Then immediately start daily infusion of mesna 1200 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        in 2000 mL 5 percent dextrose in water with 100 mEq/L sodium acetate, 20 mEq/L of potassium acetate, and 4 mEq/L of magnesium sulfate; and administer over 22 hours on day 1. For days 2 through 5, the total dose of mesna with electrolytes is administered over 24 hours per day. Total concentration of mesna should not exceed 20 mg/mL.",
"       </td>",
"       <td>",
"        Days 1 through 5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Hydration:",
"        </strong>",
"        Adequate hydration (at least two liters of oral or IV fluids per day) should be maintained with ifosfamide to reduce the risk of bladder toxicity",
"        <sup>",
"         [2]",
"        </sup>",
"        . Refer to UpToDate topic on \"Cystitis in patients with cancer\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        HIGH (&gt;90 percent risk of emesis). Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\". Concomitant administration of aprepitant may increase the risk of ifosfamide neurotoxicity",
"        <sup>",
"         [3-5]",
"        </sup>",
"        ; its use is avoided at some institutions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Prophylaxis for infusion reactions:",
"        </strong>",
"        There is no standard premedication regimen. Refer to UpToDate topic on \"Infusion reactions to systemic chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Vesicant/irritant properties:",
"        </strong>",
"        Doxorubicin is a vesicant; avoid extravasation. Administer infusional regimens through a central venous line. Refer to UpToDate topic on \"Extravasation injury from chemotherapy and other non-neoplastic vesicants\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Infection prophylaxis:",
"        </strong>",
"        The risk of febrile neutropenia with this regimen was &gt;20 percent",
"        <sup>",
"         [1]",
"        </sup>",
"        . Therefore, primary prophylaxis with granulocyte colony stimulating factors is justified. Refer to UpToDate topic on \"Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for baseline liver or renal dysfunction:",
"        </strong>",
"        In the original protocol, patients were excluded if they had a baseline total bilirubin of greater than 1.5 mg/dL or a serum creatinine of greater than 1.5 mg/dL",
"        <sup>",
"         [1]",
"        </sup>",
"        . A lower initial ifosfamide dose may be needed for patients with preexisting renal or liver impairment. A lower starting dose of doxorubicin may be needed for patients with preexisting liver impairment",
"        <sup>",
"         [6]",
"        </sup>",
"        . Refer to UpToDate topics on \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\" and \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Cardiac issues:",
"        </strong>",
"        Doxorubicin is associated with cardiomyopathy, the incidence of which is related to the cumulative dose. Assess baseline LVEF prior to administration. Doxorubicin is contraindicated for patients with recent myocardial infarction, severe myocardial dysfunction, severe arrhythmia, or previous therapy with high cumulative doses of doxorubicin or any other anthracyclines",
"        <sup>",
"         [6]",
"        </sup>",
"        . Refer to UpToDate topic on \"Cardiotoxicity of anthracycline-like chemotherapy agents\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; CBC with differential and platelet count weekly during treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Ifosfamide is associated with cumulative nephrotoxicity, mostly at a total dose above 60 grams/m",
"        <sup>",
"         2",
"        </sup>",
"        . Clinical manifestations may include hypophosphatemia, renal potassium wasting, metabolic acidosis with a normal ion gap, and rarely, polyuria due to nephrogenic diabetes insipidus. Assess creatinine and electrolytes, including potassium and phosphate, daily during treatment and prior to each subsequent treatment cycle. Refer to UpToDate topic on \"Ifosfamide nephrotoxicity\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Mesna does not prevent hemorrhagic cystitis in all patients",
"        <sup>",
"         [7]",
"        </sup>",
"        . Monitor a morning specimen of urine for hematuria daily, on days 1 through 5. Refer to UpToDate topic on \"Cystitis in patients with cancer\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor for neurotoxicity (confusion, coma, rarely seizures, weakness, neuropathy, ataxia, cranial nerve dysfunction) daily on days 1 through 5. Central nervous system side effects may be especially problematic for those over age 60. Refer to UpToDate topic on \"Neurologic complications of non-platinum cancer chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Assess liver function tests prior to each treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor cumulative doxorubicin dose. Reassess LVEF periodically during therapy as clinically indicated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose alterations for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        In the original protocol, initial dose modification for treatment related toxicity included a decrease in ifosfamide dose from 10,000 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        to 8000 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per cycle, with the same doxorubicin dose (75 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per cycle); the second level of dose reduction was a decrease in doxorubicin dose to 60 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per cycle, in addition to the reduced ifosfamide dose of 8000 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per cycle",
"        <sup>",
"         [1]",
"        </sup>",
"        . Additional dose modification guidelines were not provided. If ifosfamide dose is adjusted, the mesna dose should also be modified to maintain the mesna-to-ifosfamide ratio (mesna dose 60 percent of the daily ifosfamide dose).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Myelotoxicity:",
"        </strong>",
"        Delay treatment cycle until the absolute neutrophil count is &ge;1500 cells/mm",
"        <sup>",
"         3",
"        </sup>",
"        and platelet count is &ge;100,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        . Dose reduce for a failure to recover platelets to 100,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        by day 28 or thrombocytopenia with bleeding, or requirement for platelet transfusions for seven or more days, and for febrile neutropenia with significant morbidity (documented infection or sepsis syndrome) despite use of granulocyte colony stimulating factors",
"        <sup>",
"         [1]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Neurologic toxicity:",
"        </strong>",
"        Although formal guidelines are not provided by the manufacturer, reduce the ifosfamide dose or administer the same dose over a greater number of days for reversible grade 2 to 3 central nervous system toxicity",
"        <sup>",
"         [1]",
"        </sup>",
"        . Discontinue for &ge;grade 3 toxicity. Refer to UpToDate topic on \"Neurologic complications of non-platinum cancer chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Renal toxicity:",
"        </strong>",
"        In the original protocol, ifosfamide dose reduction was recommended for a day 1 serum creatinine of 1.8 mg/dL or greater",
"        <sup>",
"         [1]",
"        </sup>",
"        . If ifosfamide dose is adjusted, the mesna dose should also be modified to maintain the mesna-to-ifosfamide ratio (mesna dose 60 percent of the daily ifosfamide dose).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Bladder toxicity:",
"        </strong>",
"        If microscopic hematuria (greater than 10 RBC per high power field) is present, withhold ifosfamide until complete resolution. Although formal guidelines are not available, dose reduce ifosfamide for patients with grade 3 or worse urotoxicity that has not responded to increases in IV fluids or mesna",
"        <sup>",
"         [1]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Other toxicity:",
"        </strong>",
"        For patients with grade 3 or worse mucositis, reduce duration of doxorubicin infusion to two days; if recurrent grade 3 or 4 mucositis, reduce the daily dose by 20 percent",
"        <sup>",
"         [1]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         If there is a change in body weight of at least 10 percent, doses should be recalculated.",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     IV: intravenous; LVEF: left ventricular ejection fraction; CBC: complete blood count; RBC: red blood cells.",
"     <br/>",
"     * If necessary, oral mesna may be used; however, oral mesna is not recommended for the initial dose",
"     <sup>",
"      [8]",
"     </sup>",
"     . If the oral route is chosen, patients should receive an initial IV dose of mesna (at 20 percent of the daily dose of ifosfamide) prior to the day 1 ifosfamide administration, followed by oral mesna tablets at 40 percent of the daily ifosfamide dose per dose, administered at two and six hours after the initiation of each dose of ifosfamide. This same dosing schedule is repeated on each day that ifosfamide is administered. The total daily mesna dose is 100 percent of the ifosfamide dose when the oral route is used. If patients vomit within two hours of taking a dose of mesna, they should repeat the dose or receive an IV dose of mesna",
"     <sup>",
"      [9]",
"     </sup>",
"     .",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Patel SR, et al. Am J Clin Oncol 1998; 21:317.",
"      </li>",
"      <li>",
"       IFEX (ifosfamide) injection. US FDA-approved package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed January 3, 2012.)",
"      </li>",
"      <li>",
"       Durand JP, et al. Ann Oncol 2007; 18:808.",
"      </li>",
"      <li>",
"       Jarkowski A. Am J Health-Syst Pharm 2008; 65:2229.",
"      </li>",
"      <li>",
"       Howell JE, et al. J Oncol Pharm Practice 2008; 14:157.",
"      </li>",
"      <li>",
"       Adriamycin (doxorubicin hydrochloride) injection. US FDA-approved package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed January 3, 2012).",
"      </li>",
"      <li>",
"       MESNA injection (solution). US FDA-approved package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed January 3, 2012).",
"      </li>",
"      <li>",
"       Hensley ML, et al. J Clin Oncol 2009; 27:127.",
"      </li>",
"      <li>",
"       MESNEX (mesna) tablets. US FDA-approved package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed January 3, 2012).",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_42_2735=[""].join("\n");
var outline_f2_42_2735=null;
